@NP	The Effects	1
@NP	Co-transplantation of Olfactory Ensheathing Cells	16
@NP	Co-transplantation	16
@NP	Olfactory Ensheathing Cells	38
@NP	Schwann Cells	70
@NP	Local Inflammation Environment	87
@NP	the Contused Spinal Cord	121
@NP	spinal cord injury -LRB- SCI -RRB-	313
@NP	spinal cord injury	313
@NP	SCI	333
@NP	regulation of the repair process	354
@NP	regulation	354
@NP	the repair process	368
@NP	Olfactory ensheathing cells -LRB- OECs -RRB- and Schwann cells -LRB- SCs -RRB-	388
@NP	Olfactory ensheathing cells -LRB- OECs -RRB-	388
@NP	Olfactory ensheathing cells	388
@NP	OECs	417
@NP	Schwann cells -LRB- SCs -RRB-	427
@NP	Schwann cells	427
@NP	SCs	442
@NP	important donor cells for repairing SCI in different animal models	451
@NP	important donor cells	451
@NP	SCI in different animal models	487
@NP	SCI	487
@NP	different animal models	494
@NP	synergistic or complementary effects	528
@NP	co-transplantation of both cells for this purpose	568
@NP	co-transplantation	568
@NP	both cells for this purpose	590
@NP	both cells	590
@NP	this purpose	605
@NP	the present study	661
@NP	we	680
@NP	the effects of co-transplantation of OECs and SCs	696
@NP	the effects	696
@NP	co-transplantation of OECs and SCs	711
@NP	co-transplantation	711
@NP	OECs and SCs	733
@NP	expression of pro- or anti-inflammatory factor	749
@NP	expression	749
@NP	pro- or anti-inflammatory factor	763
@NP	polarization of macrophages in the injured spinal cord of rats	800
@NP	polarization	800
@NP	macrophages in the injured spinal cord of rats	816
@NP	macrophages	816
@NP	the injured spinal cord of rats	831
@NP	the injured spinal cord	831
@NP	rats	858
@NP	Mixed cell suspensions containing OECs and SCs	864
@NP	Mixed cell suspensions	864
@NP	OECs and SCs	898
@NP	the injured site at 7 days	934
@NP	the injured site	934
@NP	7 days	954
@NP	contusion	967
@NP	the vertebral T10 level	980
@NP	the DMEM , SC , or OEC group	1019
@NP	the co-transplantation group	1047
@NP	a more extensive distribution of the grafted cells	1080
@NP	a more extensive distribution	1080
@NP	the grafted cells	1113
@NP	number	1157
@NP	astrocytes	1167
@NP	microglia/macrophage infiltration	1179
@NP	expression of chemokines -LRB- CCL2 and CCL3 -RRB-	1218
@NP	expression	1218
@NP	chemokines -LRB- CCL2 and CCL3 -RRB-	1232
@NP	chemokines	1232
@NP	CCL2 and CCL3	1244
@NP	CCL2	1244
@NP	CCL3	1253
@NP	the injured site	1262
@NP	The co-transplantation group	1280
@NP	arginase + / CD206 + macrophages -LRB- IL-4 -RRB-	1338
@NP	arginase + / CD206 + macrophages	1338
@NP	arginase +	1338
@NP	arginase	1338
@NP	+	1346
@NP	CD206 + macrophages	1348
@NP	CD206	1348
@NP	macrophages	1355
@NP	IL-4	1368
@NP	iNOS	1388
@NP	+	1392
@NP	CD16/32 + macrophages	1395
@NP	IFN-γ	1417
@NP	higher IL-10 and IL-13	1447
@NP	higher IL-10	1447
@NP	IL-13	1464
@NP	lower IL-6 and TNF-α in their expression levels , a smaller cystic cavity area ,	1474
@NP	lower IL-6 and TNF-α	1474
@NP	their expression levels , a smaller cystic cavity area ,	1498
@NP	their expression levels	1498
@NP	a smaller cystic cavity area	1523
@NP	motor functions	1566
@NP	These results	1583
@NP	OEC and SC co-transplantation	1611
@NP	the shift of the macrophage phenotype	1655
@NP	the shift	1655
@NP	the macrophage phenotype	1668
@NP	M -LRB- IFN-γ -RRB-	1698
@NP	M	1698
@NP	IFN-γ	1700
@NP	M -LRB- IL-4 -RRB-	1710
@NP	M	1710
@NP	IL-4	1712
@NP	inflammatory cell infiltration in the injured site	1726
@NP	inflammatory cell infiltration	1726
@NP	the injured site	1760
@NP	inflammatory factors and chemokine expression	1791
@NP	a better immune environment for SCI repair	1852
@NP	a better immune environment	1852
@NP	SCI repair	1884
@NP	Keywords Olfactory ensheathing cells .	1896
@NP	Keywords	1896
@NP	Olfactory ensheathing cells	1905
@NP	Schwann cells .	1935
@NP	Spinal cord injury .	1951
@NP	Spinal cord	1951
@NP	injury	1963
@NP	Inflammatory response .	1972
@NP	Macrophage phenotypes	1996
@NP	Introduction Inflammatory responses following spinal cord injury -LRB- SCI -RRB-	2019
@NP	Introduction Inflammatory responses	2019
@NP	spinal cord injury -LRB- SCI -RRB-	2065
@NP	spinal cord injury	2065
@NP	SCI	2085
@NP	vascular permeability and extravasation	2108
@NP	large numbers of neutrophils and monocytes/macrophages	2151
@NP	large numbers	2151
@NP	neutrophils and monocytes/macrophages	2168
@NP	tissues	2211
@NP	the functions of these cells	2231
@NP	the functions	2231
@NP	these cells	2248
@NP	inflammatory factors	2289
@NP	The dynamic balance among inflammatory factors	2311
@NP	The dynamic balance	2311
@NP	inflammatory factors	2337
@NP	the activation	2374
@NP	astrocytes and macrophages	2392
@NP	tissue damage	2441
@NP	tissue repair	2466
@NP	-LSB- 1 , 2	2480
@NP	cell transplantation	2499
@NP	one of the most promising methods for the treatment of SCI	2523
@NP	one	2523
@NP	the most promising methods for the treatment of SCI	2530
@NP	the most promising methods	2530
@NP	the treatment of SCI	2561
@NP	the treatment	2561
@NP	SCI	2578
@NP	Previous reports	2583
@NP	the use	2603
@NP	donor cells including olfactory ensheathing cells -LRB- OECs -RRB-	2614
@NP	donor cells	2614
@NP	olfactory ensheathing cells -LRB- OECs -RRB-	2636
@NP	olfactory ensheathing cells	2636
@NP	OECs	2665
@NP	Schwann cells -LRB- SCs -RRB-	2672
@NP	Schwann cells	2672
@NP	SCs	2687
@NP	bone marrow stromal cells	2693
@NP	bone marrow	2693
@NP	stromal cells	2705
@NP	neural stem cells	2720
@NP	embryonic stem cells	2743
@NP	limited success for this purpose	2779
@NP	limited success	2779
@NP	this purpose	2799
@NP	animal experiments -LSB- 3	2815
@NP	animal experiments	2815
@NP	3	2835
@NP	7 -RSB-	2837
@NP	Numerous studies	2841
@NP	OECs	2874
@NP	necrotic or apoptotic neural cells	2891
@NP	remyelination	2935
@NP	multiple neurotrophins -LSB- 8 , 9 -RSB-	2962
@NP	multiple neurotrophins	2962
@NP	8	2986
@NP	SCs	2993
@NP	basement membrane components including type IV collagen and laminin	3005
@NP	basement membrane components	3005
@NP	type IV collagen and laminin	3044
@NP	type IV collagen	3044
@NP	laminin	3065
@NP	axonal regeneration	3085
@NP	10 -RSB-	3106
@NP	It	3111
@NP	co-transplantation of OECs and SCs	3148
@NP	co-transplantation	3148
@NP	OECs and SCs	3170
@NP	motor function	3217
@NP	SCI -LSB- 11 , 12 -RSB-	3238
@NP	We	3251
@NP	this synergistic effect	3270
@NP	the regulation	3310
@NP	inflammatory responses after SCI	3328
@NP	inflammatory responses	3328
@NP	SCI	3357
@NP	the biological characteristics of the donor cell itself	3377
@NP	the biological characteristics	3377
@NP	the donor cell itself	3411
@NP	the donor cell	3411
@NP	The inflammatory responses after SCI	3434
@NP	The inflammatory responses	3434
@NP	SCI	3467
@NP	a dynamic balance of the macrophage activation -LSB- 13 -RSB-	3502
@NP	a dynamic balance	3502
@NP	the macrophage activation -LSB- 13 -RSB-	3523
@NP	the macrophage activation	3523
@NP	13 -RSB-	3550
@NP	Macrophages activated by IFN-γ , as means of M -LRB- IFN-γ -RRB- ,	3555
@NP	Macrophages	3555
@NP	IFN-γ	3580
@NP	means of M -LRB- IFN-γ -RRB-	3590
@NP	means	3590
@NP	M -LRB- IFN-γ -RRB-	3599
@NP	M	3599
@NP	IFN-γ	3601
@NP	neurotoxic effects	3617
@NP	macrophages	3643
@NP	IL-4	3668
@NP	means of M -LRB- IL-4 -RRB-	3677
@NP	means	3677
@NP	M -LRB- IL-4 -RRB-	3686
@NP	M	3686
@NP	IL-4	3688
@NP	harmful immune responses	3707
@NP	damage repair	3751
@NP	-LSB- 14 , 15 -RSB-	3765
@NP	Only very few studies	3775
@NP	the regulatory effects of cell transplantation	3813
@NP	the regulatory effects	3813
@NP	cell transplantation	3839
@NP	phagocytes	3875
@NP	SCI -LSB- 16 -RSB-	3889
@NP	SCI -LSB-	3889
@NP	no study	3913
@NP	the synergistic effects of co-transplantation of two cell types	3959
@NP	the synergistic effects	3959
@NP	co-transplantation of two cell types	3986
@NP	co-transplantation	3986
@NP	two cell types	4008
@NP	regulation of macrophage activation following SCI	4026
@NP	regulation	4026
@NP	macrophage activation following SCI	4040
@NP	macrophage activation	4040
@NP	SCI	4072
@NP	the present study	4080
@NP	OECs and SCs	4099
@NP	the injured spinal cord	4138
@NP	the synergistic effects	4177
@NP	the local inflammation environment	4204
@NP	the histological changes in the injured spinal cord	4254
@NP	the histological changes	4254
@NP	the injured spinal cord	4282
@NP	The present results	4307
@NP	co-implantation of OECs and SCs	4339
@NP	co-implantation	4339
@NP	OECs and SCs	4358
@NP	expression levels	4393
@NP	pro- and anti-inflammatory factors	4414
@NP	increased percentage of Arg	4472
@NP	increased percentage	4472
@NP	Arg	4496
@NP	CD206 + cells	4502
@NP	CD206	4502
@NP	cells	4509
@NP	percentage of iNOS	4527
@NP	percentage	4527
@NP	iNOS	4541
@NP	+	4545
@NP	CD16/32 + cells	4547
@NP	CD16/32	4547
@NP	cells	4556
@NP	These effects	4563
@NP	the immune microenvironment	4591
@NP	the repair of local tissues	4628
@NP	the repair	4628
@NP	local tissues	4642
@NP	motor function of the contused rats	4669
@NP	motor function	4669
@NP	the contused rats	4687
@NP	Materials and Methods Animals All the animals	4707
@NP	Materials	4707
@NP	Methods Animals All the animals	4721
@NP	Methods Animals	4721
@NP	All the animals	4737
@NP	the Third Military Medical University -LRB- TMMU -RRB- guidelines	4778
@NP	TMMU	4817
@NP	surgical procedures and post-operative care	4839
@NP	surgical procedures	4839
@NP	post-operative care	4863
@NP	accordance	4901
@NP	protocols approved by the TMMU Institutional Animal Care and Use Committee	4917
@NP	protocols	4917
@NP	the TMMU Institutional Animal Care and Use Committee	4939
@NP	Preparation of OECs from Rats OECs	4993
@NP	Preparation	4993
@NP	OECs from Rats OECs	5008
@NP	OECs	5008
@NP	Rats OECs	5018
@NP	the olfactory bulbs	5048
@NP	adult green fluorescent protein-transgenic -LRB- GFP-Tg -RRB- rats	5071
@NP	Sprague Dawley -LRB- SD -RRB- rats	5131
@NP	SD	5147
@NP	a previously described method -LSB- 17 -RSB-	5162
@NP	a previously described method	5162
@NP	17 -RSB-	5193
@NP	the caudal two thirds of the olfactory bulbs	5207
@NP	the caudal two thirds	5207
@NP	the olfactory bulbs	5232
@NP	meninges and white matter	5274
@NP	meninges	5274
@NP	white matter	5287
@NP	scalpel blades	5313
@NP	25 min in 0.125 % trypsin -LRB- Gibco , USA -RRB-	5347
@NP	25 min	5347
@NP	0.125 % trypsin -LRB- Gibco , USA -RRB-	5357
@NP	0.125 % trypsin	5357
@NP	Gibco	5374
@NP	USA	5381
@NP	37 °C in a 5 % CO2 incubator	5389
@NP	37 °C	5389
@NP	a 5 % CO2 incubator	5398
@NP	Tissue	5417
@NP	The cell suspension	5477
@NP	1 h in Dulbecco 's modified Eagle medium -LRB- DMEM -RRB-	5515
@NP	1 h	5515
@NP	Dulbecco 's modified Eagle medium -LRB- DMEM -RRB-	5522
@NP	Dulbecco 's modified Eagle medium	5522
@NP	Dulbecco 's	5522
@NP	DMEM	5556
@NP	F12 medium supplemented with 10 % fetal calf serum -LRB- FCS , Gibco , USA -RRB-	5562
@NP	F12 medium	5562
@NP	10 % fetal calf serum -LRB- FCS , Gibco , USA -RRB-	5591
@NP	10 % fetal calf serum	5591
@NP	FCS	5614
@NP	Gibco	5619
@NP	USA	5626
@NP	the non-adherent cells	5659
@NP	the cultures	5690
@NP	the same medium	5720
@NP	10 ng/ml basic fibroblast growth factor -LRB- bFGF -RRB-	5754
@NP	10 ng/ml	5754
@NP	basic fibroblast growth factor -LRB- bFGF -RRB-	5763
@NP	basic fibroblast growth factor	5763
@NP	bFGF	5795
@NP	2 μM forskolin -LRB- Sigma , USA -RRB-	5806
@NP	2 μM forskolin	5806
@NP	Sigma	5822
@NP	USA	5829
@NP	the cells	5840
@NP	confluence	5863
@NP	they	5875
@NP	the purity of OECs	5898
@NP	the purity	5898
@NP	OECs	5912
@NP	immunostaining of anti-S100 and anti-P75	5934
@NP	immunostaining	5934
@NP	anti-S100 and anti-P75	5952
@NP	Abcam , USA	5985
@NP	The OEC preparations	5998
@NP	> 95 %	6041
@NP	>	6041
@NP	S100 and p75	6061
@NP	a second passage	6081
@NP	the cells	6099
@NP	1.0 ×	6140
@NP	105 cells/μl for transplantation	6146
@NP	105 cells/μl	6146
@NP	transplantation	6163
@NP	Preparation of SCs from Rats SCs	6180
@NP	Preparation	6180
@NP	SCs from Rats SCs	6195
@NP	SCs	6195
@NP	Rats SCs	6204
@NP	the sciatic nerves of adult GFP-Tg rats or SD rats	6232
@NP	the sciatic nerves	6232
@NP	adult GFP-Tg rats or SD rats	6254
@NP	adult GFP-Tg rats	6254
@NP	SD rats	6275
@NP	18 -RSB-	6309
@NP	removal of the epineurium , connective tissue , and blood vessels	6333
@NP	removal	6333
@NP	the epineurium , connective tissue , and blood vessels	6344
@NP	the epineurium	6344
@NP	connective tissue	6360
@NP	blood vessels	6383
@NP	sciatic nerve explants	6398
@NP	approximately 1 mm3	6435
@NP	2 h	6473
@NP	1.25 U/ml dispase	6480
@NP	0.05 % collagenase	6499
@NP	15 % FCS	6519
@NP	25 mM HEPES in DMEM -LRB- all from Gibco , USA -RRB-	6533
@NP	25 mM HEPES	6533
@NP	DMEM -LRB- all from Gibco , USA -RRB-	6548
@NP	DMEM	6548
@NP	all from Gibco , USA	6554
@NP	all	6554
@NP	Gibco , USA	6563
@NP	37 °C in a 5 % CO2 incubator	6578
@NP	37 °C	6578
@NP	a 5 % CO2 incubator	6587
@NP	the explants	6614
@NP	two to three times in DMEM	6639
@NP	two to three times	6639
@NP	DMEM	6661
@NP	35-mm tissue culture dishes	6682
@NP	DMEM/10 % FCS -LRB- 750 μl/dish -RRB-	6721
@NP	DMEM/10 % FCS	6721
@NP	750	6736
@NP	the outgrowth around the explants	6755
@NP	the outgrowth	6755
@NP	the explants	6776
@NP	a near-confluent monolayer -LRB- 7 -- 10 days -RRB-	6797
@NP	a near-confluent monolayer	6797
@NP	7 -- 10 days	6825
@NP	7	6825
@NP	10 days	6827
@NP	the explants	6837
@NP	new dishes	6870
@NP	fresh medium	6892
@NP	this process	6906
@NP	4 -- 5 weeks	6937
@NP	4	6937
@NP	5 weeks	6939
@NP	this time	6951
@NP	the outgrowth	6962
@NP	SCs	6996
@NP	The explants	7001
@NP	enzymatic digestion	7041
@NP	the cells	7102
@NP	confluence	7125
@NP	they	7137
@NP	the purity of SCs	7160
@NP	the purity	7160
@NP	SCs	7174
@NP	immunostaining of anti-S100 -LRB- Abcam , USA -RRB-	7195
@NP	immunostaining	7195
@NP	anti-S100 -LRB- Abcam , USA -RRB-	7213
@NP	anti-S100	7213
@NP	Abcam	7224
@NP	USA	7231
@NP	At least 80 % of the cells	7237
@NP	At least 80 %	7237
@NP	the cells	7252
@NP	S100	7286
@NP	The cells	7292
@NP	1.0 ×	7333
@NP	105 cells/μl for transplantation	7339
@NP	105 cells/μl	7339
@NP	transplantation	7356
@NP	Animal Model of Spinal Cord Injury Adult female SD rats -LRB- 200 -- 250 g -RRB-	7373
@NP	Animal Model of Spinal Cord Injury Adult female SD rats	7373
@NP	Animal Model	7373
@NP	Spinal Cord Injury Adult female SD rats	7389
@NP	200 -- 250 g	7430
@NP	200	7430
@NP	250 g	7434
@NP	a single intraperitoneal injection	7464
@NP	1 % sodium pentobarbiturate -LRB- 30 mg/kg -RRB-	7502
@NP	1 % sodium pentobarbiturate	7502
@NP	30 mg/kg	7531
@NP	A sterile laminectomy	7542
@NP	the vertebral T10 level	7581
@NP	the dura	7624
@NP	The spinal cord	7634
@NP	an NYU-II impactor	7669
@NP	a weight of 10.0 g released from 25 mm above the exposed cord	7693
@NP	a weight	7693
@NP	10.0 g released from 25 mm above the exposed cord	7705
@NP	10.0 g	7705
@NP	25 mm above the exposed cord	7726
@NP	25 mm	7726
@NP	the exposed cord	7738
@NP	injury	7762
@NP	the muscles and skin	7770
@NP	the muscles	7770
@NP	skin	7786
@NP	layers	7806
@NP	The procedure	7814
@NP	hind limb paralysis	7840
@NP	all the animals	7863
@NP	Bicillin -LRB- 60,000 U/kg , intramuscular route -RRB-	7880
@NP	Bicillin	7880
@NP	60,000 U/kg , intramuscular route	7890
@NP	60,000 U/kg	7890
@NP	intramuscular route	7903
@NP	7 days after contusion	7951
@NP	7 days	7951
@NP	contusion	7964
@NP	wound and bladder infections	7985
@NP	bladder expression performed twice daily	8020
@NP	bladder expression	8020
@NP	Cell Transplantation Cell transplantation	8062
@NP	Cell Transplantation	8062
@NP	Cell transplantation	8083
@NP	the seventh day	8121
@NP	spinal cord injury using a previously described method -LSB- 17 -RSB-	8143
@NP	spinal cord injury	8143
@NP	a previously described method -LSB- 17 -RSB-	8168
@NP	a previously described method	8168
@NP	17 -RSB-	8199
@NP	rats	8213
@NP	the laminectomy site	8240
@NP	Cell suspensions -LRB- 1.0 × 105 cells/μl for SCs , OECs , or SCs + OECs -RRB-	8277
@NP	Cell suspensions	8277
@NP	1.0 × 105 cells/μl for SCs , OECs , or SCs + OECs	8295
@NP	1.0 ×	8295
@NP	105 cells/μl for SCs , OECs , or SCs + OECs	8301
@NP	105 cells/μl	8301
@NP	SCs , OECs , or SCs + OECs	8318
@NP	SCs	8318
@NP	OECs	8323
@NP	SCs + OECs	8332
@NP	OECs	8336
@NP	a surgical microscope	8362
@NP	a Hamilton syringe , which remained in place for 5 min after each injection	8390
@NP	a Hamilton syringe	8390
@NP	place for 5 min	8428
@NP	place	8428
@NP	5 min	8438
@NP	each injection	8450
@NP	Cells	8466
@NP	the midline	8492
@NP	cord	8520
@NP	a depth of 0.8 mm	8528
@NP	a depth	8528
@NP	0.8 mm	8539
@NP	the epicenter of the lesion	8549
@NP	the epicenter	8549
@NP	the lesion	8566
@NP	1 mm	8584
@NP	caudal to the epicenter	8601
@NP	caudal	8601
@NP	the epicenter	8611
@NP	2 μl per injection	8626
@NP	2 μl	8626
@NP	injection	8635
@NP	a total of 6 μl of cell suspension	8646
@NP	a total	8646
@NP	6 μl of cell suspension	8657
@NP	6 μl	8657
@NP	cell suspension	8665
@NP	co-transplantation of SCs and OECs	8696
@NP	co-transplantation	8696
@NP	SCs and OECs	8718
@NP	the 1:1 proportion	8732
@NP	mixed suspension of 3 μl SCs and 3 μl OECs	8761
@NP	mixed suspension	8761
@NP	3 μl SCs and 3 μl OECs	8781
@NP	3 μl SCs	8781
@NP	3 μl OECs	8794
@NP	Control animals	8806
@NP	identical volumes of DMEM	8841
@NP	identical volumes	8841
@NP	DMEM	8862
@NP	the same sites	8870
@NP	the injection	8892
@NP	the muscle and skin	8907
@NP	interrupted sutures	8944
@NP	The migration and the distribution of transplanted cells	8965
@NP	The migration	8965
@NP	the distribution of transplanted cells	8983
@NP	the distribution	8983
@NP	transplanted cells	9003
@NP	five longitudinal sections	9040
@NP	every fifth serial section	9081
@NP	the five host cords selected at random from each group	9126
@NP	the five host cords	9126
@NP	each group	9170
@NP	The digital images	9182
@NP	× 20	9219
@NP	Adobe Photoshop 10.0	9241
@NP	measurements	9276
@NP	The total migration distance	9290
@NP	the longitudinal axis of the host cord	9330
@NP	the longitudinal axis	9330
@NP	the host cord	9355
@NP	the total distribution area of the fluorescence cells within the cord	9373
@NP	the total distribution area	9373
@NP	the fluorescence cells within the cord	9404
@NP	the fluorescence cells	9404
@NP	the cord	9434
@NP	Image	9462
@NP	Pro Plus 6.0 -LRB- Media Cybemetics Inc. , Silver Spring , USA -RRB-	9468
@NP	Pro	9468
@NP	6.0	9477
@NP	Media Cybemetics Inc. , Silver Spring , USA	9482
@NP	Media Cybemetics Inc.	9482
@NP	Silver Spring	9505
@NP	USA	9520
@NP	Tissue Processing and Histopathology The spinal cord	9526
@NP	Tissue Processing	9526
@NP	Histopathology The spinal cord	9548
@NP	Histopathology	9548
@NP	The spinal cord	9563
@NP	4 % paraformaldehyde	9607
@NP	post-fixed in the same fixative for 24 h , then overnight in 30 % sucrose	9632
@NP	the same fixative for 24 h , then overnight in 30 %	9646
@NP	the same fixative	9646
@NP	24 h , then overnight in 30 %	9668
@NP	24 h	9668
@NP	then overnight in 30 %	9674
@NP	then overnight	9674
@NP	30 %	9692
@NP	1 week after transplantation	9708
@NP	1 week	9708
@NP	transplantation	9721
@NP	Segments of the spinal cord centered on the impact site	9738
@NP	Segments	9738
@NP	the spinal cord centered on the impact site	9750
@NP	the spinal cord	9750
@NP	the impact site	9778
@NP	optimal cutting temperature compound -LRB- OCT -RRB-	9811
@NP	optimal cutting temperature compound	9811
@NP	OCT	9849
@NP	serial 10-μm-thick sagittal sections	9864
@NP	a cryostat -LRB- Leica -RRB- for histopathology	9904
@NP	a cryostat -LRB- Leica -RRB-	9904
@NP	a cryostat	9904
@NP	Leica	9916
@NP	histopathology	9927
@NP	− 70 °C -LRB- n = 3 rats / group -RRB-	9957
@NP	− 70 °C	9957
@NP	n = 3 rats / group	9965
@NP	n	9965
@NP	= 3 rats / group	9966
@NP	= 3 rats	9966
@NP	3	9968
@NP	group	9976
@NP	Slides	9984
@NP	PBS for 10 min	10020
@NP	PBS	10020
@NP	10 min	10028
@NP	The sections	10036
@NP	0.3 % Triton X-100	10073
@NP	0.3 %	10073
@NP	Triton X-100	10079
@NP	10 % normal goat serum	10109
@NP	0.01 M PBS for 2 h.	10135
@NP	0.01 M PBS	10135
@NP	2 h.	10150
@NP	Sections	10155
@NP	overnight	10184
@NP	4 °C with polyclonal rabbit	10197
@NP	4 °C	10197
@NP	polyclonal rabbit	10207
@NP	anti-glial fibrillary acidic protein -LRB- GFAP , 1:3000 -RRB-	10225
@NP	anti-glial fibrillary acidic protein	10225
@NP	GFAP , 1:3000	10263
@NP	GFAP	10263
@NP	1:3000	10269
@NP	astrocytes	10281
@NP	mouse anti-Iba1 -LRB- 1:100 -RRB-	10293
@NP	mouse anti-Iba1	10293
@NP	1:100	10310
@NP	microglias/macrophages	10321
@NP	rabbit anti-iNOS -LRB- 1:100 -RRB-	10345
@NP	rabbit anti-iNOS	10345
@NP	1:100	10363
@NP	mouse	10374
@NP	32 -LRB- 1:200 -RRB- for M -LRB- IFN-γ -RRB-	10390
@NP	32 -LRB- 1:200 -RRB-	10390
@NP	32	10390
@NP	1:200	10394
@NP	M -LRB- IFN-γ -RRB-	10405
@NP	M	10405
@NP	IFN-γ	10407
@NP	rabbit anti-arginase-1 -LRB- 1:500 -RRB-	10420
@NP	rabbit anti-arginase-1	10420
@NP	1:500	10444
@NP	mouse anti-CD206 -LRB- 1:1000 ; all from Abcam , Cambridge , MA , USA -RRB-	10455
@NP	mouse anti-CD206	10455
@NP	1:1000 ; all from Abcam , Cambridge , MA , USA	10473
@NP	1:1000	10473
@NP	all from Abcam , Cambridge , MA , USA	10481
@NP	all from Abcam , Cambridge , MA ,	10481
@NP	all	10481
@NP	Abcam , Cambridge , MA ,	10490
@NP	USA	10512
@NP	M -LRB- IL-4 -RRB-	10521
@NP	M	10521
@NP	IL-4	10523
@NP	immunohistochemical staining	10534
@NP	the sections	10564
@NP	HRP-conjugated secondary antibodies -LRB- 1:200 ; Abcam , USA -RRB- for 2 h	10597
@NP	HRP-conjugated secondary antibodies -LRB- 1:200 ; Abcam , USA -RRB-	10597
@NP	HRP-conjugated secondary antibodies	10597
@NP	1:200 ; Abcam , USA	10634
@NP	1:200	10634
@NP	Abcam , USA	10641
@NP	2 h	10657
@NP	room temperature	10664
@NP	incubation for 5 min with 0.02 % DAB	10688
@NP	incubation	10688
@NP	5 min with 0.02 % DAB	10703
@NP	5 min	10703
@NP	0.02 % DAB	10714
@NP	0.02 %	10714
@NP	DAB	10721
@NP	the sections	10726
@NP	hematoxylin	10764
@NP	immunofluorescence staining	10781
@NP	the sections	10810
@NP	anti-mouse TRITC-conjugated antibody	10843
@NP	1:200 ; Beyotime	10881
@NP	1:200	10881
@NP	Beyotime	10888
@NP	People 's Republic of China	10898
@NP	People 's Republic	10898
@NP	People 's	10898
@NP	China	10919
@NP	anti-rabbit FITC-conjugated antibody	10930
@NP	1:200 ; Beyotime	10968
@NP	1:200	10968
@NP	Beyotime	10975
@NP	People 's Republic of China	10985
@NP	People 's Republic	10985
@NP	People 's	10985
@NP	China	11006
@NP	2 h at room temperature	11017
@NP	2 h	11017
@NP	room temperature	11024
@NP	Nuclei	11042
@NP	Hoechst33342 -LRB- 5 μg/ml ; Beyotime , People 's Republic of China -RRB-	11067
@NP	Hoechst33342	11067
@NP	5 μg/ml ; Beyotime	11081
@NP	5 μg/ml	11081
@NP	Beyotime	11090
@NP	People 's Republic of China	11100
@NP	People 's Republic	11100
@NP	People 's	11100
@NP	China	11121
@NP	Five sections	11129
@NP	every fifth serial section	11162
@NP	three animals	11207
@NP	each group	11221
@NP	The images	11233
@NP	20 ×	11265
@NP	Adobe Photoshop 10.0	11287
@NP	Areas of positive immunoreactivity	11309
@NP	Areas	11309
@NP	positive immunoreactivity	11318
@NP	Image	11361
@NP	Pro Plus 6.0	11367
@NP	Pro	11367
@NP	6.0	11376
@NP	The proportion of the GFAP and Iba1 positive areas	11381
@NP	The proportion	11381
@NP	the GFAP and Iba1 positive areas	11399
@NP	the GFAP	11399
@NP	Iba1 positive areas	11412
@NP	a percentage of DMEM group	11464
@NP	a percentage	11464
@NP	DMEM group	11480
@NP	The number of iNOS + / CD16/32 + cells and arginase-1 + / CD206 + cells	11492
@NP	The number of iNOS + / CD16/32 + cells and arginase-1 + /	11492
@NP	The number	11492
@NP	iNOS + / CD16/32 + cells and arginase-1 + /	11506
@NP	iNOS +	11506
@NP	iNOS	11506
@NP	+	11510
@NP	CD16/32 + cells and arginase-1	11512
@NP	CD16/32 + cells	11512
@NP	arginase-1	11531
@NP	+	11541
@NP	CD206 + cells	11543
@NP	a permillage of the total cells -LRB- blue fluorescence -RRB- in five sections	11585
@NP	a permillage	11585
@NP	the total cells -LRB- blue fluorescence -RRB- in five sections	11601
@NP	the total cells -LRB- blue fluorescence -RRB-	11601
@NP	the total cells	11601
@NP	blue fluorescence	11618
@NP	five sections	11640
@NP	Histological Assessment HE staining	11655
@NP	Histological Assessment	11655
@NP	HE staining	11679
@NP	allowmeasurement of area of the cystic cavities within spinal cord sections	11708
@NP	allowmeasurement	11708
@NP	area of the cystic cavities within spinal cord sections	11728
@NP	area	11728
@NP	the cystic cavities within spinal cord sections	11736
@NP	the cystic cavities	11736
@NP	spinal cord sections	11763
@NP	6 weeks	11787
@NP	transplantation	11801
@NP	Five longitudinal sections of the injury epicenter from each animal	11818
@NP	Five longitudinal sections	11818
@NP	the injury epicenter from each animal	11848
@NP	the injury epicenter	11848
@NP	each animal	11874
@NP	every fifth serial section -LRB- n = 6/group -RRB-	11905
@NP	every fifth serial section	11905
@NP	n = 6/group	11933
@NP	n	11933
@NP	= 6/group	11934
@NP	The digital images	11945
@NP	× 20	11981
@NP	an Olympus CCD camera	11991
@NP	Adobe Photoshop 10.0	12031
@NP	The total area of cavities	12053
@NP	The total area	12053
@NP	cavities	12071
@NP	Image	12099
@NP	Pro Plus 6.0	12105
@NP	Pro	12105
@NP	6.0	12114
@NP	Media Cybemetics Inc. , Silver Spring ,	12120
@NP	Media Cybemetics Inc.	12120
@NP	Silver Spring	12143
@NP	Western Blotting Spinal cord segments 5 mm long centered on the injury epicenter	12164
@NP	Western Blotting Spinal cord segments	12164
@NP	5 mm	12202
@NP	the injury epicenter	12224
@NP	1	12262
@NP	week	12264
@NP	transplantation	12275
@NP	Total proteins	12292
@NP	a total protein	12328
@NP	kit -LRB- keygen , People 's Republic of China -RRB-	12354
@NP	kit	12354
@NP	keygen , People 's Republic of China	12359
@NP	keygen	12359
@NP	People 's Republic of China	12367
@NP	People 's Republic	12367
@NP	People 's	12367
@NP	China	12388
@NP	the kit manufacturer 's recommended protocol	12408
@NP	the kit manufacturer 's	12408
@NP	SDS PAGE -LRB- 12 % gels ; n = 3/group -RRB-	12469
@NP	SDS PAGE	12469
@NP	12 % gels ; n = 3/group	12479
@NP	12 % gels	12479
@NP	n = 3/group	12488
@NP	Western blotting	12500
@NP	standard techniques	12537
@NP	equal amounts of protein loaded into each well	12563
@NP	equal amounts	12563
@NP	protein loaded into each well	12580
@NP	protein	12580
@NP	each	12600
@NP	The intensity of immunostaining	12963
@NP	The intensity	12963
@NP	immunostaining	12980
@NP	HRP-conjugated secondary antibodies -LRB- all from Abcam , USA -RRB-	13016
@NP	HRP-conjugated secondary antibodies	13016
@NP	all from Abcam , USA	13053
@NP	all	13053
@NP	Abcam , USA	13062
@NP	a commercially available kit	13078
@NP	enhanced chemiluminescence -LRB- ECL ; Amersham , USA -RRB-	13111
@NP	enhanced chemiluminescence	13111
@NP	ECL ; Amersham , USA	13139
@NP	ECL	13139
@NP	Amersham , USA	13144
@NP	All Western blots	13160
@NP	a chemiluminescence system -LRB- GE Healthcare , UK -RRB-	13199
@NP	a chemiluminescence system	13199
@NP	GE Healthcare	13227
@NP	UK	13242
@NP	data	13251
@NP	Quantity One 4.2.1 software -LRB- Bio-Rad , USA -RRB-	13276
@NP	Quantity One 4.2.1 software	13276
@NP	Quantity One	13276
@NP	4.2.1 software	13289
@NP	Bio-Rad	13305
@NP	USA	13314
@NP	The intensity of each band	13320
@NP	The intensity	13320
@NP	each band	13337
@NP	that of β-actin	13373
@NP	that	13373
@NP	β-actin	13381
@NP	Enzyme-Linked Immunosorbent Assay Commercially available	13390
@NP	Enzyme-Linked Immunosorbent Assay	13390
@NP	sandwich enzyme-linked immunosorbent assay	13447
@NP	ELISA	13491
@NP	kits	13498
@NP	protein expression of the following cytokines	13523
@NP	protein expression	13523
@NP	the following cytokines	13545
@NP	IL-4 and IFN-γ -LRB- all from Abcam , USA -RRB-	13570
@NP	IL-4 and IFN-γ	13570
@NP	all from Abcam , USA	13586
@NP	all	13586
@NP	Abcam , USA	13595
@NP	inflammation and neuroplasticity	13625
@NP	the spinal cord and the chemokines CCL2 and CCL3	13661
@NP	the spinal cord	13661
@NP	the chemokines CCL2 and CCL3	13681
@NP	all fromYuanyanbio , People 's Republic of China	13711
@NP	all fromYuanyanbio	13711
@NP	People 's Republic of China	13731
@NP	People 's Republic	13731
@NP	People 's	13731
@NP	China	13752
@NP	The spinal cord segments 5 mm long centered on the epicenter	13760
@NP	The spinal cord segments	13760
@NP	5 mm	13785
@NP	the epicenter	13807
@NP	1	13838
@NP	week	13840
@NP	transplantation -LRB- n = 3 / group -RRB-	13851
@NP	transplantation	13851
@NP	n = 3 / group	13868
@NP	n	13868
@NP	= 3 / group	13869
@NP	= 3	13869
@NP	group	13873
@NP	Pre-cooling PBS -LRB- 1 ml -RRB-	13881
@NP	Pre-cooling PBS	13881
@NP	1 ml	13898
@NP	tissue homogenization	13918
@NP	an electric homogenizer -LRB- FSH-2 , People 's Republic of China -RRB-	13945
@NP	an electric homogenizer	13945
@NP	FSH-2 , People 's Republic of China	13970
@NP	FSH-2	13970
@NP	People 's Republic of China	13977
@NP	People 's Republic	13977
@NP	People 's	13977
@NP	China	13998
@NP	homogenates	14010
@NP	20,000 × g , 4 °C	14045
@NP	20,000 × g	14045
@NP	4 °C	14055
@NP	30 min	14064
@NP	The supernatant	14073
@NP	ELISA analysis	14107
@NP	the kit manufacturer 's recommended protocol	14135
@NP	the kit manufacturer 's	14135
@NP	The optical density of each well	14180
@NP	The optical density	14180
@NP	each well	14203
@NP	a microplate reader -LRB- Molecular Devices SpectraMax M5 -RRB-	14234
@NP	a microplate reader	14234
@NP	Molecular Devices SpectraMax M5	14255
@NP	Molecular Devices	14255
@NP	SpectraMax M5	14273
@NP	450 nm	14291
@NP	Assessment of Locomotor Behavior	14299
@NP	Assessment	14299
@NP	Locomotor Behavior	14313
@NP	the Basso-Beattie-Bresnahan -LRB- BBB -RRB- locomotor rating scale -LSB-	14338
@NP	BBB	14367
@NP	all the rats	14401
@NP	locomotor function	14430
@NP	two observers blinded to the treatment groups	14452
@NP	two observers	14452
@NP	the treatment groups	14477
@NP	BBB testing	14499
@NP	the day of spinal cord injury	14538
@NP	the day	14538
@NP	spinal cord injury	14549
@NP	6 weeks	14571
@NP	Somatosensory Evoked	14601
@NP	Potential Recording and Analysis	14622
@NP	6 weeks	14658
@NP	transplantation	14672
@NP	12 rats -LRB- n = 3 in each group -RRB-	14689
@NP	12 rats	14689
@NP	n = 3 in each group	14698
@NP	n = 3	14698
@NP	n	14698
@NP	3	14701
@NP	each group	14706
@NP	3 % sodium pentobarbiturate	14741
@NP	atropine sulfate -LRB- 0.8 mg/kg -RRB-	14811
@NP	atropine sulfate	14811
@NP	0.8 mg/kg	14829
@NP	tracheal secretions	14853
@NP	Sciatic nerves	14874
@NP	a bipolar platinum wire electrode with positive current pulses of 5 mA magnitude	14924
@NP	a bipolar platinum wire electrode	14924
@NP	positive current pulses of 5 mA magnitude	14963
@NP	positive current pulses	14963
@NP	5 mA magnitude	14990
@NP	2 ms duration	15006
@NP	2 ms	15006
@NP	duration	15011
@NP	4 Hz frequency	15025
@NP	Somatosensory	15041
@NP	potential -LRB- SEP -RRB-	15062
@NP	potential	15062
@NP	SEP	15073
@NP	a Neuropack -LRB- Nihon Kohden Co , Japan -RRB-	15099
@NP	a Neuropack	15099
@NP	Nihon Kohden Co	15112
@NP	Japan	15129
@NP	a monopolar silver ball placed on the surface of the sensorimotor cortex	15141
@NP	a monopolar silver ball	15141
@NP	the surface of the sensorimotor cortex	15175
@NP	the surface	15175
@NP	the sensorimotor cortex	15190
@NP	bregma − 2 mm , lateral 2 mm	15215
@NP	bregma −	15215
@NP	2 mm , lateral 2 mm	15223
@NP	2 mm	15223
@NP	lateral 2 mm	15229
@NP	2	15237
@NP	The effect of electrical stimulation on SEP	15244
@NP	The effect	15244
@NP	electrical stimulation on SEP	15258
@NP	electrical stimulation	15258
@NP	SEP	15284
@NP	terms of latency and amplitude	15304
@NP	terms	15304
@NP	latency and amplitude	15313
@NP	Statistical Analysis All values	15336
@NP	Statistical Analysis	15336
@NP	All values	15357
@NP	mean ± standard deviation	15385
@NP	Statistical differences	15412
@NP	one-way factorial analysis of variance -LRB- ANOVA -RRB-	15458
@NP	one-way factorial analysis	15458
@NP	variance -LRB- ANOVA -RRB-	15488
@NP	variance	15488
@NP	ANOVA	15498
@NP	Fisher 's least significant different -LRB- LSD -RRB- post hoc analysis	15509
@NP	Fisher 's least significant different -LRB- LSD -RRB-	15509
@NP	Fisher 's least significant different	15509
@NP	Fisher 's	15509
@NP	LSD	15547
@NP	post hoc analysis	15552
@NP	a P value	15571
@NP	statistical significance	15595
@NP	All statistical analyses	15621
@NP	SPSS software version	15667
@NP	17.0 -LRB- SPSS Inc. , Chicago , IL , USA -RRB-	15689
@NP	17.0	15689
@NP	SPSS Inc. , Chicago , IL , USA	15695
@NP	SPSS Inc.	15695
@NP	Chicago	15706
@NP	IL	15715
@NP	USA	15719
@NP	Results Table 1	15726
@NP	Results	15726
@NP	Table 1	15734
@NP	Area and distribution of transplanted cells in the injured spinal cord Fig.	15742
@NP	Area	15742
@NP	distribution of transplanted cells in the injured spinal cord Fig.	15751
@NP	distribution	15751
@NP	transplanted cells in the injured spinal cord Fig.	15767
@NP	transplanted cells	15767
@NP	the injured spinal cord Fig.	15789
@NP	1	15819
@NP	Migration and distribution of GFP-OECs	15821
@NP	Migration and distribution	15821
@NP	GFP-OECs	15851
@NP	GFP-SCs in the injured spinal cord at 1 week and 6 weeks	15867
@NP	GFP-SCs	15867
@NP	the injured spinal cord at 1 week and 6 weeks	15878
@NP	the injured spinal cord	15878
@NP	1 week and 6 weeks	15905
@NP	1 week	15905
@NP	6 weeks	15916
@NP	transplantation	15930
@NP	The migration distance	15947
@NP	the donor cells in the SC + OEC cotransplantation group	15973
@NP	the donor cells	15973
@NP	the SC + OEC cotransplantation group	15992
@NP	the SC	15992
@NP	OEC cotransplantation group	16000
@NP	the distribution	16044
@NP	that in the other groups	16085
@NP	that	16085
@NP	the other groups	16093
@NP	6 weeks	16113
@NP	Scale bar = 200 μm Fig. 2 SC + OEC cotransplantation	16143
@NP	Scale	16143
@NP	= 200 μm Fig. 2 SC + OEC cotransplantation	16152
@NP	= 200 μm Fig. 2 SC	16152
@NP	OEC cotransplantation	16172
@NP	astrocyte and microglia/macrophage infiltration of the injured spinal cord	16202
@NP	astrocyte and microglia/macrophage infiltration	16202
@NP	the injured spinal cord	16253
@NP	1 week post-transplantation	16280
@NP	GFAP and Iba1 expression levels	16309
@NP	SC + OEC co-transplantation	16367
@NP	SC	16367
@NP	OEC co-transplantation	16371
@NP	that	16408
@NP	the DMEM , SC , and OEC groups	16416
@NP	immunohistochemical staining -LRB- a , c -RRB-	16458
@NP	immunohistochemical staining	16458
@NP	a , c	16488
@NP	a	16488
@NP	c	16491
@NP	orWestern blotting analysis -LRB- b , d -RRB-	16494
@NP	orWestern blotting analysis	16494
@NP	Scale	16530
@NP	50 μm	16540
@NP	P <	16549
@NP	P	16549
@NP	<	16550
@NP	0.05	16551
@NP	P	16560
@NP	0.01 Fig.	16562
@NP	3 Expression	16573
@NP	cytokines -LRB- IL-4 and IFN-γ -RRB- and chemokines -LRB- CCL2 and CCL3 -RRB-	16589
@NP	cytokines	16589
@NP	IL-4 and IFN-γ	16600
@NP	IL-4	16600
@NP	IFN-γ	16609
@NP	chemokines	16620
@NP	CCL2 and CCL3	16632
@NP	CCL2	16632
@NP	CCL3	16641
@NP	the spinal cord	16650
@NP	1 week after cell transplantation	16669
@NP	1 week	16669
@NP	cell transplantation	16682
@NP	the SC + OEC co-transplantation group	16707
@NP	the SC	16707
@NP	OEC co-transplantation group	16716
@NP	IFN-γ , CCL2 , and CCL3 levels	16746
@NP	those of the DMEM , SC , and OEC groups	16812
@NP	those	16812
@NP	the DMEM , SC , and OEC groups	16821
@NP	the IL-4 level	16859
@NP	Western blotting analysis -LRB- a , b -RRB- or ELISA analysis -LRB- c -RRB-	16902
@NP	Western blotting analysis	16902
@NP	a , b	16929
@NP	a	16929
@NP	b	16932
@NP	ELISA analysis	16938
@NP	c	16954
@NP	One asterisk P < 0.05 , two asterisks	16958
@NP	One asterisk P	16958
@NP	< 0.05 , two asterisks	16972
@NP	<	16972
@NP	0.05 , two asterisks	16973
@NP	P	16993
@NP	< 0.01 Fig.	16994
@NP	<	16994
@NP	0.01 Fig.	16995
@NP	4 Immunofluorescence staining	17006
@NP	differences	17043
@NP	the expression of iNOS and CD16/32	17058
@NP	the expression	17058
@NP	iNOS and CD16/32	17076
@NP	markers of IFN-γ-induced macrophages	17096
@NP	markers	17096
@NP	IFN-γ-induced macrophages	17107
@NP	arginase-1 and CD206 as markers of IL-4	17138
@NP	arginase-1 and CD206	17138
@NP	markers of IL-4	17162
@NP	markers	17162
@NP	IL-4	17173
@NP	macrophages	17187
@NP	1 week post-transplantation	17203
@NP	the SC + OEC co-transplantation group	17235
@NP	the SC	17235
@NP	OEC co-transplantation group	17243
@NP	the number of iNOS +	17273
@NP	the number	17273
@NP	iNOS +	17287
@NP	iNOS	17287
@NP	+	17291
@NP	CD16/32 + cells decreased , and the number of arginase-1 +	17294
@NP	CD16/32 + cells	17294
@NP	the number	17324
@NP	arginase-1	17338
@NP	+	17348
@NP	CD206 + cells	17351
@NP	those in the DMEM , SC , and OEC groups -LRB- P < 0.05 -RRB-	17386
@NP	those	17386
@NP	the DMEM , SC , and OEC groups	17395
@NP	P < 0.05	17425
@NP	P	17425
@NP	< 0.05	17426
@NP	<	17426
@NP	0.05	17427
@NP	Scale	17434
@NP	= 100 μm Fig. 5 Expression	17443
@NP	pro-inflammatory factors	17473
@NP	IL-6 and TNF-α	17499
@NP	IL-6	17499
@NP	TNF-α	17508
@NP	anti-inflammatory factors	17519
@NP	IL-10 and IL-13	17546
@NP	IL-10	17546
@NP	IL-13	17556
@NP	the spinal cord at 1 week after cell transplantation	17566
@NP	the spinal cord	17566
@NP	1 week after cell transplantation	17585
@NP	1 week	17585
@NP	cell transplantation	17598
@NP	those of the DMEM , SC , and OEC groups	17634
@NP	those	17634
@NP	the DMEM , SC , and OEC groups	17643
@NP	the levels of IL-6 and TNF-α in the SC + OEC cotransplantation group	17673
@NP	the levels	17673
@NP	IL-6 and TNF-α in the SC + OEC cotransplantation group	17687
@NP	IL-6 and TNF-α	17687
@NP	the SC + OEC cotransplantation group	17705
@NP	the SC	17705
@NP	OEC cotransplantation group	17714
@NP	the levels of IL-10 and IL-13	17774
@NP	the levels	17774
@NP	IL-10 and IL-13	17788
@NP	One asterisk P	17834
@NP	0.05 , two asterisks P < 0.01 Fig. 6 Co-transplantation of OECs and SCs	17851
@NP	0.05	17851
@NP	two asterisks P <	17857
@NP	two asterisks	17857
@NP	P <	17871
@NP	P	17871
@NP	<	17872
@NP	0.01 Fig.	17873
@NP	6 Co-transplantation of OECs and SCs	17884
@NP	6 Co-transplantation	17884
@NP	OECs and SCs	17908
@NP	the area of cystic cavities induced by SCI	17929
@NP	the area	17929
@NP	cystic cavities induced by SCI	17941
@NP	cystic cavities	17941
@NP	SCI	17968
@NP	6 weeks	17975
@NP	cell transplantation	17989
@NP	Scale	18011
@NP	1 cm	18021
@NP	the photographs of the injured spinal cord	18029
@NP	the photographs	18029
@NP	the injured spinal cord	18048
@NP	Scale	18073
@NP	1 mm	18083
@NP	the micrographs	18091
@NP	The histogram	18108
@NP	the area of cystic cavities	18126
@NP	the area	18126
@NP	cystic cavities	18138
@NP	the injury epicenter in each group at 6 weeks after SCI	18157
@NP	the injury epicenter	18157
@NP	each group at 6 weeks after SCI	18181
@NP	each group	18181
@NP	6 weeks after SCI	18195
@NP	6 weeks	18195
@NP	SCI	18209
@NP	One asterisk P < 0.05 , two asterisks	18214
@NP	One asterisk P	18214
@NP	<	18229
@NP	0.05 , two asterisks	18231
@NP	0.05	18231
@NP	two asterisks	18237
@NP	P <	18251
@NP	0.01 Fig. 7 Changes in BBB scores	18253
@NP	0.01 Fig. 7 Changes	18253
@NP	BBB scores	18277
@NP	the day of spinal cord injury to 6 weeks after cell transplantation	18293
@NP	the day	18293
@NP	spinal cord injury to 6 weeks after cell transplantation	18304
@NP	spinal cord injury	18304
@NP	6 weeks after cell transplantation	18326
@NP	6 weeks	18326
@NP	cell transplantation	18340
@NP	A significant improvement in hindlimb motor function	18362
@NP	A significant improvement	18362
@NP	hindlimb motor function	18391
@NP	the SC + OEC cotransplantation group	18431
@NP	the SC	18431
@NP	OEC cotransplantation group	18440
@NP	the DMEM , SC , and OEC groups	18482
@NP	3 to 6 weeks	18516
@NP	transplantation	18535
@NP	Two number signs P < 0.01 vs DMEM group , two diamonds P < 0.01 vs.	18552
@NP	Two number signs	18552
@NP	P < 0.01 vs DMEM group , two diamonds P <	18569
@NP	P < 0.01	18569
@NP	P <	18569
@NP	P	18569
@NP	0.01	18573
@NP	DMEM group , two diamonds P <	18581
@NP	DMEM group	18581
@NP	two diamonds P <	18593
@NP	two diamonds	18593
@NP	<	18608
@NP	0.01 vs.	18610
@NP	SC group , one asterisk P < 0.05 vs.	18619
@NP	SC group , one asterisk P	18619
@NP	SC group	18619
@NP	one asterisk P	18629
@NP	< 0.05 vs.	18644
@NP	<	18644
@NP	0.05 vs.	18646
@NP	OEC group , two asterisks P < 0.01 vs.	18655
@NP	OEC group , two asterisks	18655
@NP	OEC group	18655
@NP	two asterisks	18666
@NP	P < 0.01 vs.	18680
@NP	P <	18680
@NP	P	18680
@NP	0.01 vs.	18682
@NP	OEC group Fig. 8 SEP	18691
@NP	OEC group Fig.	18691
@NP	8 SEP	18707
@NP	all experiment groups	18734
@NP	the sixth week	18759
@NP	transplantation	18780
@NP	The amplitude	18797
@NP	the latency	18829
@NP	the SC + OEC group compared to theDMEM , SC	18858
@NP	the SC + OEC group	18858
@NP	theDMEM , SC	18888
@NP	OEC groups	18905
@NP	P < 0.05	18917
@NP	P	18917
@NP	< 0.05	18918
@NP	<	18918
@NP	0.05	18919
@NP	Co-implantation of OECs and SCs	18926
@NP	Co-implantation	18926
@NP	OECs and SCs	18945
@NP	the Migration and Distribution	18967
@NP	the	19001
@NP	Cells	19015
@NP	The distribution and migration of transplanted GFP cells in each group	19021
@NP	The distribution and migration	19021
@NP	transplanted GFP cells in each group	19055
@NP	transplanted GFP cells	19055
@NP	each group	19081
@NP	1 week and 6 weeks post-transplantation	19109
@NP	1 week	19109
@NP	6 weeks post-transplantation	19120
@NP	cells	19163
@NP	clusters	19190
@NP	only very limited cell migration outward	19204
@NP	only very limited cell migration	19204
@NP	there	19250
@NP	no significant differences	19261
@NP	the	19291
@NP	distance and distribution area between each group at 1	19304
@NP	distance and distribution area	19304
@NP	each group at 1	19343
@NP	each group	19343
@NP	1	19357
@NP	week	19359
@NP	transplantation	19370
@NP	transplanted cell migration	19396
@NP	adjacent tissues with band-shaped distribution	19431
@NP	adjacent tissues	19431
@NP	band-shaped distribution	19453
@NP	6 weeks	19494
@NP	addition	19527
@NP	co-transplantation of OECs and SCs	19547
@NP	co-transplantation	19547
@NP	OECs and SCs	19569
@NP	green fluorescent cells	19583
@NP	the injured area -LRB- Fig. 1 -RRB-	19621
@NP	the injured area	19621
@NP	Fig. 1	19639
@NP	the distribution area	19653
@NP	0.396 ± 0.051 mm2	19678
@NP	0.396 ±	19678
@NP	0.051 mm2	19686
@NP	migration distance	19700
@NP	2.845 ±	19722
@NP	0.448 mm	19730
@NP	that in the SC or OEC group -LRB- P < 0.05 , Table 1 -RRB-	19788
@NP	that	19788
@NP	the SC or OEC group -LRB- P < 0.05 , Table 1 -RRB-	19796
@NP	the SC or OEC group	19796
@NP	P	19817
@NP	< 0.05 , Table 1	19818
@NP	<	19818
@NP	0.05	19819
@NP	Table 1	19825
@NP	These findings	19835
@NP	the grafted cells	19862
@NP	6 weeks	19895
@NP	co-transplantation	19908
@NP	the migration and distribution of the implanted cells in the injured spinal cord	19936
@NP	the migration and distribution	19936
@NP	the implanted cells in the injured spinal cord	19970
@NP	the implanted cells	19970
@NP	the injured spinal cord	19993
@NP	Co-implantation of OECs and SCs	20018
@NP	Co-implantation	20018
@NP	OECs and SCs	20037
@NP	the Infiltration of Astrocytes and Microglias/Macrophages	20058
@NP	the Infiltration	20058
@NP	Astrocytes and Microglias/Macrophages	20078
@NP	Astrocytes	20078
@NP	Microglias/Macrophages	20093
@NP	the effects of co-implantation of OECs and SCs	20128
@NP	the effects	20128
@NP	co-implantation of OECs and SCs	20143
@NP	co-implantation	20143
@NP	OECs and SCs	20162
@NP	astrocyte and microglia/macrophage infiltration	20178
@NP	SCI rats	20229
@NP	immunohistochemical staining andWestern blotting	20239
@NP	the expression	20349
@NP	GFAP	20367
@NP	astrocyte marker	20373
@NP	Iba1	20395
@NP	microglia	20401
@NP	macrophage marker	20412
@NP	macrophage	20412
@NP	marker	20423
@NP	the injured spinal cord	20443
@NP	immunohistochemical staining results	20480
@NP	the DMEM control group	20532
@NP	the expressions of GFAP and Iba1	20556
@NP	the expressions	20556
@NP	GFAP and Iba1	20575
@NP	28.2 ± 8.3	20594
@NP	28.2 ±	20594
@NP	8.3	20600
@NP	51.5 ± 7.7 % in the SC+OEC group	20608
@NP	51.5 ±	20608
@NP	the SC+OEC group	20623
@NP	60.0 ± 11.1 and 75.5 ± 12.6 % in the OEC group	20641
@NP	60.0 ± 11.1	20641
@NP	60.0 ±	20641
@NP	11.1	20647
@NP	75.5 ± 12.6 % in the OEC group	20656
@NP	75.5 ±	20656
@NP	the OEC group	20672
@NP	133.8 ±	20691
@NP	19.5 and 98.2 ± 17.9 %	20699
@NP	the SC group , respectively -LRB- Fig. 2a , c -RRB-	20724
@NP	the SC group , respectively	20724
@NP	the SC group	20724
@NP	Fig. 2a , c	20752
@NP	Fig. 2a	20752
@NP	c	20761
@NP	Western blotting analysis	20768
@NP	the densities of GFAP and Iba1 bands	20795
@NP	the densities	20795
@NP	GFAP and Iba1 bands	20812
@NP	the SC+OEC group	20860
@NP	those in the DMEM , SC , and OEC groups	20891
@NP	those	20891
@NP	the DMEM , SC , and OEC groups	20900
@NP	P < 0.05	20930
@NP	P	20930
@NP	< 0.05	20931
@NP	<	20931
@NP	0.05	20932
@NP	Fig. 2b , d	20938
@NP	Fig. 2b	20938
@NP	d	20947
@NP	Co-implantation of OECs and SCs	20951
@NP	Co-implantation	20951
@NP	OECs and SCs	20970
@NP	the Expression Levels of Chemokines	20991
@NP	the Expression Levels	20991
@NP	Chemokines	21016
@NP	Factor of Macrophages The expression of chemokines	21040
@NP	Factor	21040
@NP	Macrophages The expression of chemokines	21050
@NP	Macrophages	21050
@NP	The expression of chemokines	21062
@NP	The expression	21062
@NP	chemokines	21080
@NP	factor of macrophages at 1	21104
@NP	factor	21104
@NP	macrophages at 1	21114
@NP	macrophages	21114
@NP	1	21129
@NP	week	21131
@NP	transplantation	21142
@NP	the infiltration of inflammatory cells and the polarization of macrophages	21190
@NP	the infiltration of inflammatory cells	21190
@NP	the infiltration	21190
@NP	inflammatory cells	21210
@NP	the polarization of macrophages	21233
@NP	the polarization	21233
@NP	macrophages	21253
@NP	The expression levels of CCL2 , CCL3 , IL-4 , and IFN-γ in the injured area	21266
@NP	The expression levels	21266
@NP	CCL2 , CCL3 , IL-4 , and IFN-γ in the injured area	21291
@NP	CCL2 , CCL3 , IL-4 , and IFN-γ	21291
@NP	the injured area	21322
@NP	Western blotting and ELISA	21356
@NP	The Western blotting	21384
@NP	co-transplantation of OECs and SCs	21425
@NP	co-transplantation	21425
@NP	OECs and SCs	21447
@NP	the levels of IFN-γ , CCL2 , and CCL3	21484
@NP	the levels	21484
@NP	IFN-γ , CCL2 , and CCL3	21498
@NP	IFN-γ	21498
@NP	CCL2	21505
@NP	CCL3	21515
@NP	the levels	21534
@NP	IL-4 -LRB- P < 0.05	21548
@NP	IL-4 -LRB- P <	21548
@NP	IL-4	21548
@NP	P <	21554
@NP	P	21554
@NP	<	21555
@NP	0.05	21557
@NP	vs.	21563
@NP	DMEM , SC , and OEC groups ; Fig. 3a , b -RRB- .	21567
@NP	DMEM	21567
@NP	SC	21573
@NP	OEC groups ; Fig. 3a , b -RRB-	21581
@NP	OEC	21581
@NP	groups ; Fig. 3a , b -RRB-	21585
@NP	groups	21585
@NP	Fig. 3a , b	21593
@NP	Fig. 3a	21593
@NP	b	21602
@NP	Similar changes of the chemokines and inducing factor of macrophages	21606
@NP	Similar changes	21606
@NP	the chemokines and inducing factor of macrophages	21625
@NP	the chemokines and inducing factor	21625
@NP	macrophages	21663
@NP	ELISA -LRB- P < 0.05 , Fig. 3c -RRB-	21694
@NP	ELISA	21694
@NP	P	21701
@NP	< 0.05 , Fig. 3c	21702
@NP	<	21702
@NP	0.05	21703
@NP	Fig. 3c	21709
@NP	Co-implantation	21719
@NP	OECs and SCs	21738
@NP	the Activation of Macrophages Immunofluorescent staining of the tissues	21759
@NP	the Activation	21759
@NP	Macrophages Immunofluorescent staining of the tissues	21777
@NP	Macrophages	21777
@NP	the tissues	21819
@NP	1 week	21848
@NP	the effects of co-transplantation of OECs and SCs	21888
@NP	the effects	21888
@NP	co-transplantation of OECs and SCs	21903
@NP	co-transplantation	21903
@NP	OECs and SCs	21925
@NP	macrophage activation	21941
@NP	iNOS and CD16/32	21964
@NP	the markers of M -LRB- IFN-γ -RRB-	21985
@NP	the markers	21985
@NP	M -LRB- IFN-γ -RRB-	22000
@NP	M	22000
@NP	IFN-γ	22002
@NP	arginase-1 and CD206	22016
@NP	the markers of M -LRB- IL-4 -RRB-	22041
@NP	the markers	22041
@NP	M -LRB- IL-4 -RRB-	22056
@NP	M	22056
@NP	IL-4	22058
@NP	The results	22065
@NP	a lower proportion of iNOS	22089
@NP	a lower proportion	22089
@NP	iNOS	22111
@NP	CD16/32 + cells	22117
@NP	CD16/32	22117
@NP	cells	22126
@NP	the SC + OEC group -LRB- 9.28 ± 1.02 ‰	22145
@NP	the SC + OEC group	22145
@NP	9.28 ± 1.02 ‰	22164
@NP	9.28 ±	22164
@NP	1.02 ‰	22171
@NP	P	22178
@NP	0.05 ; Fig. 4a	22182
@NP	0.05	22182
@NP	Fig. 4a	22188
@NP	the DMEM -LRB- 34.00 ± 4.96 ‰ -RRB-	22214
@NP	the DMEM	22214
@NP	34.00 ± 4.96 ‰	22224
@NP	34.00 ±	22224
@NP	4.96 ‰	22231
@NP	SC -LRB- 25.53 ± 2.38 ‰ -RRB-	22239
@NP	SC	22239
@NP	25.53 ± 2.38 ‰	22243
@NP	25.53 ±	22243
@NP	2.38 ‰	22251
@NP	OEC -LRB- 16.87 ± 1.26 ‰ -RRB-	22263
@NP	OEC	22263
@NP	16.87 ± 1.26 ‰	22268
@NP	16.87 ±	22268
@NP	1.26 ‰	22276
@NP	the numbers of arginase-1 + / CD206 + cells	22303
@NP	the numbers	22303
@NP	arginase-1 + / CD206 + cells	22318
@NP	arginase-1 +	22318
@NP	arginase-1	22318
@NP	+	22328
@NP	CD206 + cells	22330
@NP	CD206	22330
@NP	cells	22337
@NP	the SC+OEC group	22358
@NP	16.04 ± 3.33 ‰	22376
@NP	16.04 ±	22376
@NP	3.33 ‰	22384
@NP	P < 0.05 ; Fig. 4b -RRB-	22391
@NP	P	22391
@NP	0.05 ; Fig. 4b	22393
@NP	0.05	22393
@NP	Fig. 4b	22399
@NP	those of the DMEM -LRB- 4.24 ± 0.06 ‰ -RRB- , SC -LRB- 6.91 ± 0.34 ‰ -RRB- ,	22413
@NP	those of the DMEM	22413
@NP	those	22413
@NP	the DMEM	22422
@NP	4.24 ± 0.06 ‰	22432
@NP	4.24 ±	22432
@NP	0.06 ‰	22439
@NP	SC -LRB- 6.91 ± 0.34 ‰ -RRB-	22447
@NP	SC	22447
@NP	6.91 ± 0.34 ‰	22451
@NP	6.91 ±	22451
@NP	0.34 ‰	22457
@NP	OEC -LRB- 9.67 ± 2.10 ‰	22469
@NP	OEC	22469
@NP	9.67 ± 2.10 ‰	22474
@NP	9.67 ±	22474
@NP	2.10 ‰	22481
@NP	Co-implantation of OECs and SCs	22496
@NP	Co-implantation	22496
@NP	OECs and SCs	22515
@NP	the Expression Levels of Pro- and Anti-inflammatory Factors	22536
@NP	the Expression Levels	22536
@NP	Pro- and Anti-inflammatory Factors	22561
@NP	addition	22599
@NP	evaluation of the inflammation environment	22611
@NP	evaluation	22611
@NP	the inflammation environment	22625
@NP	the expression of pro- and anti-inflammatory factors	22655
@NP	the expression	22655
@NP	pro- and anti-inflammatory factors	22673
@NP	the functions and mechanisms of inflammatory cells	22741
@NP	the functions and mechanisms	22741
@NP	inflammatory cells	22773
@NP	The expression levels	22793
@NP	TNF-α , IL-6 , IL-10 , and IL-13 in the injured spinal cord	22818
@NP	TNF-α , IL-6 , IL-10 , and IL-13	22818
@NP	the injured spinal cord	22851
@NP	Western blotting	22894
@NP	The results	22912
@NP	co-transplantation of OECs and SCs	22936
@NP	co-transplantation	22936
@NP	OECs and SCs	22958
@NP	the levels of IL-6 and TNF-α	22995
@NP	the levels	22995
@NP	IL-6 and TNF-α	23009
@NP	the levels of IL-10 and IL-13 -LRB- P < 0.05 ,	23039
@NP	the levels of IL-10	23039
@NP	the levels	23039
@NP	IL-10	23053
@NP	IL-13 -LRB- P < 0.05 ,	23063
@NP	IL-13	23063
@NP	P < 0.05	23070
@NP	P <	23070
@NP	P	23070
@NP	0.05	23073
@NP	vs.	23079
@NP	DMEM , SC , and OEC groups ; Fig. 5 -RRB- .	23083
@NP	DMEM	23083
@NP	SC	23089
@NP	OEC groups ; Fig. 5 -RRB-	23097
@NP	OEC	23097
@NP	groups ; Fig. 5 -RRB-	23101
@NP	groups	23101
@NP	Fig. 5	23109
@NP	Fig.	23109
@NP	5	23114
@NP	These results	23118
@NP	co-transplantation	23147
@NP	expression of pro-inflammatory factors -LRB- TNF-α and IL-6 -RRB-	23177
@NP	expression	23177
@NP	pro-inflammatory factors -LRB- TNF-α and IL-6 -RRB-	23191
@NP	pro-inflammatory factors	23191
@NP	TNF-α and IL-6	23217
@NP	TNF-α	23217
@NP	IL-6	23227
@NP	the expression of anti-inflammatory factors -LRB- IL-10 and IL-13 -RRB-	23247
@NP	the expression	23247
@NP	anti-inflammatory factors	23265
@NP	IL-10 and IL-13	23292
@NP	IL-10	23292
@NP	IL-13	23302
@NP	the CNS after SCI	23312
@NP	the CNS	23312
@NP	SCI	23326
@NP	Co-implantation of OECs and SCs	23331
@NP	Co-implantation	23331
@NP	OECs and SCs	23350
@NP	the Area of Cystic Cavities	23371
@NP	the Area	23371
@NP	Cystic Cavities	23383
@NP	6 weeks	23402
@NP	the injured part of the spinal cord in the DMEM group	23432
@NP	the injured part	23432
@NP	the spinal cord in the DMEM group	23452
@NP	the spinal cord	23452
@NP	the DMEM group	23471
@NP	that of the SC , OEC , and SC+OEC groups in gross morphology	23524
@NP	that	23524
@NP	the SC , OEC , and SC+OEC groups in gross morphology	23532
@NP	the SC	23532
@NP	OEC	23540
@NP	SC+OEC groups in gross morphology	23549
@NP	SC+OEC groups	23549
@NP	gross morphology	23566
@NP	a light microscope	23590
@NP	larger cystic cavities	23610
@NP	6.083 ±	23645
@NP	0.566 mm2	23651
@NP	the DMEM group	23665
@NP	The cystic cavities in the SC+OEC group -LRB- 1.183 ± 0.189 mm2 -RRB-	23681
@NP	The cystic cavities in the SC+OEC group	23681
@NP	The cystic cavities	23681
@NP	the SC+OEC group	23704
@NP	1.183 ± 0.189 mm2	23722
@NP	1.183 ±	23722
@NP	0.189 mm2	23728
@NP	P < 0.05	23759
@NP	P	23759
@NP	< 0.05	23761
@NP	<	23761
@NP	0.05	23763
@NP	those of the DMEM	23782
@NP	those	23782
@NP	the DMEM	23791
@NP	SC -LRB- 3.050 ± 0.760 mm2 -RRB-	23801
@NP	SC	23801
@NP	3.050 ± 0.760 mm2	23805
@NP	3.050 ±	23805
@NP	0.760 mm2	23812
@NP	OEC -LRB- 2.327 ± 0.581 mm2 , Fig. 6 -RRB- groups	23828
@NP	OEC	23828
@NP	2.327 ± 0.581 mm2 , Fig. 6	23833
@NP	2.327 ±	23833
@NP	0.581 mm2	23839
@NP	Fig. 6	23850
@NP	groups	23858
@NP	Co-implantation of OECs and SCs	23866
@NP	Co-implantation	23866
@NP	OECs and SCs	23885
@NP	the Recovery of Motor Function	23907
@NP	the Recovery	23907
@NP	Motor Function	23923
@NP	the Contused Rats	23941
@NP	The motor function	23959
@NP	the BBB score -LRB- n = 6 / group -RRB-	23997
@NP	the BBB score	23997
@NP	n = 6 / group	24012
@NP	n	24012
@NP	= 6 / group	24013
@NP	= 6	24013
@NP	group	24017
@NP	One day	24025
@NP	SCI	24039
@NP	all injured rats	24044
@NP	no observable hind limb movement -LRB- BBB = 0 -RRB-	24082
@NP	no observable hind limb movement	24082
@NP	BBB	24116
@NP	0	24121
@NP	the DMEM group	24128
@NP	significant motor disturbance	24144
@NP	the hind limbs of the rats at 1	24187
@NP	the hind limbs	24187
@NP	the rats at 1	24205
@NP	the rats	24205
@NP	1	24217
@NP	week	24219
@NP	some degree of recovery	24229
@NP	some degree	24229
@NP	recovery	24244
@NP	a functional plateau -LRB- BBB = 7.00 ± 1.25 -RRB-	24288
@NP	a functional plateau	24288
@NP	BBB = 7.00 ± 1.25	24310
@NP	BBB	24310
@NP	= 7.00 ± 1.25	24313
@NP	= 7.00	24313
@NP	± 1.25	24319
@NP	6 weeks	24330
@NP	an improved motor function	24350
@NP	the SC or OEC group	24395
@NP	BBB scores	24421
@NP	9.50 ± 0.701 -LRB- SC group -RRB- and 10.20 ± 1.69 -LRB- OEC group -RRB-	24435
@NP	9.50 ± 0.701 -LRB- SC group -RRB-	24435
@NP	9.50	24435
@NP	± 0.701 -LRB- SC group -RRB-	24440
@NP	± 0.701	24440
@NP	SC group	24449
@NP	10.20 ± 1.69 -LRB- OEC group -RRB-	24463
@NP	10.20	24463
@NP	± 1.69 -LRB- OEC group -RRB-	24469
@NP	± 1.69	24469
@NP	OEC group	24477
@NP	the co-transplanted group	24507
@NP	markedly better functional recovery	24540
@NP	a significantly increased BBB	24582
@NP	locomotor score -LRB- BBB = 13.70 ± 1.25 -RRB-	24612
@NP	locomotor score	24612
@NP	BBB = 13.70 ± 1.25	24629
@NP	BBB	24629
@NP	= 13.70 ± 1.25	24632
@NP	= 13.70	24632
@NP	± 1.25	24639
@NP	that of the DMEM , SC , and OEC groups at 6 weeks	24659
@NP	that	24659
@NP	the DMEM , SC , and OEC groups	24667
@NP	6 weeks	24699
@NP	Fig. 7	24708
@NP	SEP	24717
@NP	the end of the sixth week	24739
@NP	the end	24739
@NP	the sixth week	24750
@NP	transplantation	24771
@NP	all the experimental groups -LRB- Fig. 8 -RRB-	24815
@NP	all the experimental groups	24815
@NP	Fig. 8	24844
@NP	The amplitude	24853
@NP	the latency	24885
@NP	the SC+OEC group	24914
@NP	the amplitude	24936
@NP	30.19 ± 3.76 mV	24953
@NP	30.19 ±	24953
@NP	3.76 mV	24961
@NP	the latency	24973
@NP	18.8 ± 1.31 ms	24988
@NP	5.12 ± 0.82 mV and 43.6 ± 5.57 ms in the DMEM group	25015
@NP	5.12 ± 0.82 mV	25015
@NP	5.12 ±	25015
@NP	0.82 mV	25022
@NP	43.6 ± 5.57 ms in the DMEM group	25034
@NP	43.6 ± 5.57 ms	25034
@NP	the DMEM group	25052
@NP	15.27 ± 1.15 mV	25068
@NP	15.27 ±	25068
@NP	1.15 mV	25076
@NP	36.4 ± 3.12 ms in the SC group	25088
@NP	36.4 ± 3.12 ms	25088
@NP	the SC group	25106
@NP	18.87 ± 2.11 mV	25124
@NP	18.87	25124
@NP	± 2.11 mV	25130
@NP	32.2 ± 2.19 ms in the OEC group -LRB- P < 0.05 , Fig. 8 -RRB-	25144
@NP	32.2 ± 2.19 ms	25144
@NP	the OEC group -LRB- P < 0.05 , Fig. 8 -RRB-	25162
@NP	the OEC group	25162
@NP	P	25177
@NP	< 0.05 , Fig. 8	25178
@NP	<	25178
@NP	0.05	25179
@NP	Fig. 8	25185
@NP	Discussion	25195
@NP	the present study	25209
@NP	a rat contused model of SCI	25228
@NP	a rat	25228
@NP	model of SCI	25243
@NP	model	25243
@NP	SCI	25252
@NP	the effects of co-transplantation of OECs and SCs	25280
@NP	the effects	25280
@NP	co-transplantation of OECs and SCs	25295
@NP	co-transplantation	25295
@NP	OECs and SCs	25317
@NP	infiltration and activation of inflammatory cells	25333
@NP	infiltration and activation	25333
@NP	inflammatory cells	25364
@NP	improvements in the sub-acute immune microenvironment	25384
@NP	improvements	25384
@NP	the sub-acute immune microenvironment	25400
@NP	the subsequent reconstruction of spinal cord structures	25443
@NP	the subsequent reconstruction	25443
@NP	spinal cord structures	25476
@NP	recovery of motor function	25503
@NP	recovery	25503
@NP	motor function	25515
@NP	The results	25531
@NP	survival	25550
@NP	more extensive migration	25563
@NP	sub-acute co-transplanted OECs and SCs in the damaged tissues	25591
@NP	sub-acute co-transplanted OECs and SCs	25591
@NP	the damaged tissues	25633
@NP	co-transplantation of both cells	25667
@NP	co-transplantation	25667
@NP	cells	25694
@NP	the activation of astrocytes and infiltration of microglias/macrophages	25713
@NP	the activation	25713
@NP	astrocytes and infiltration	25731
@NP	microglias/macrophages	25762
@NP	The expressions of CCL2 and CCL3	25786
@NP	The expressions	25786
@NP	CCL2 and CCL3	25805
@NP	important chemokines for recruitment of immune cells	25820
@NP	important chemokines	25820
@NP	recruitment of immune cells	25845
@NP	recruitment	25845
@NP	immune cells	25860
@NP	Subtype analysis of macrophages	25895
@NP	Subtype analysis	25895
@NP	macrophages	25915
@NP	SC+OEC co-transplantation	25939
@NP	the amount of M -LRB- IL-4 -RRB- macrophages	25980
@NP	the amount	25980
@NP	M -LRB- IL-4 -RRB- macrophages	25994
@NP	IL-4	25996
@NP	the amount	26025
@NP	M	26039
@NP	IFN-γ	26041
@NP	macrophages , accompanied with increased expression of IL-4	26048
@NP	macrophages	26048
@NP	increased expression of IL-4	26078
@NP	increased expression	26078
@NP	IL-4	26102
@NP	expression of IFN-γ	26121
@NP	expression	26121
@NP	IFN-γ	26135
@NP	the immunity microenvironment of the injured cord	26148
@NP	the immunity microenvironment	26148
@NP	the injured cord	26181
@NP	co-transplantation	26218
@NP	the decreased pro-inflammatory factor -LRB- TNF-α and IL-6 -RRB- expression	26251
@NP	the decreased pro-inflammatory factor -LRB- TNF-α and IL-6 -RRB-	26251
@NP	the decreased pro-inflammatory factor	26251
@NP	TNF-α and IL-6	26290
@NP	TNF-α	26290
@NP	IL-6	26300
@NP	expression	26306
@NP	the increased anti-inflammatory factor -LRB- IL-10 and IL-13 -RRB- expression	26321
@NP	the increased anti-inflammatory factor -LRB- IL-10 and IL-13 -RRB-	26321
@NP	the increased anti-inflammatory factor	26321
@NP	IL-10 and IL-13	26361
@NP	IL-10	26361
@NP	IL-13	26371
@NP	expression	26378
@NP	These changes	26390
@NP	co-transplantation	26424
@NP	the reconstruction of tissue structures and the recovery of hind limb movement	26468
@NP	the reconstruction of tissue structures	26468
@NP	the reconstruction	26468
@NP	tissue structures	26490
@NP	the recovery of hind limb movement	26512
@NP	the recovery	26512
@NP	hind limb movement	26528
@NP	the contused rats	26559
@NP	Previous studies	26578
@NP	OECs and SCs	26611
@NP	several common features	26630
@NP	-LSB- 20	26654
@NP	22 -RSB-	26658
@NP	instance	26667
@NP	both cell types	26677
@NP	multiple cytokines	26713
@NP	nerve growth factor	26742
@NP	brain-derived neurotrophic factor	26763
@NP	neurotrophin-3	26798
@NP	fibroblast growth factor	26818
@NP	addition	26847
@NP	OECs and SCs	26857
@NP	antigenic and morphological features and transcriptional regulation mechanisms	26876
@NP	antigenic and morphological features	26876
@NP	transcriptional regulation mechanisms	26917
@NP	a cellular microenvironment that favors the repair of damage	26967
@NP	a cellular microenvironment	26967
@NP	the repair of damage	27007
@NP	the repair	27007
@NP	damage	27021
@NP	the CNS	27031
@NP	-LSB- 22 , 23 -RSB-	27039
@NP	OECs	27049
@NP	higher migration ability	27059
@NP	extensive distribution	27093
@NP	better regeneration of spinal nerve fibers	27130
@NP	better regeneration	27130
@NP	spinal nerve fibers	27153
@NP	SCs	27178
@NP	lesser capacity for migration	27194
@NP	lesser capacity	27194
@NP	migration	27214
@NP	greater remyelination ability -LSB- 17 , 24 -RSB-	27233
@NP	greater remyelination ability	27233
@NP	17	27264
@NP	It	27273
@NP	co-transplantation of OECs and SCs	27314
@NP	co-transplantation	27314
@NP	OECs and SCs	27336
@NP	spinal contusions in rats	27370
@NP	spinal contusions	27370
@NP	rats	27391
@NP	the regeneration of myelinated axons	27409
@NP	the regeneration	27409
@NP	myelinated axons	27429
@NP	the growth of 5-hydroxytryptamine fibers	27450
@NP	the growth	27450
@NP	5-hydroxytryptamine fibers	27464
@NP	hind limb motor function in injured rats	27520
@NP	hind limb motor function	27520
@NP	injured rats	27548
@NP	-LSB- 11 , 12 -RSB-	27561
@NP	the present study	27574
@NP	we	27593
@NP	co-transplantation of both cells synergistically	27622
@NP	co-transplantation	27622
@NP	both cells synergistically	27644
@NP	both cells	27644
@NP	the migration of grafted cells in the recipient tissues	27680
@NP	the migration	27680
@NP	grafted cells in the recipient tissues	27697
@NP	grafted cells	27697
@NP	the recipient tissues	27714
@NP	more extensive distribution	27748
@NP	the damaged areas	27779
@NP	addition	27801
@NP	the present results	27811
@NP	co-transplantation	27848
@NP	substantial improvement in tissue structure	27879
@NP	substantial improvement	27879
@NP	tissue structure	27906
@NP	lower cavity area and motor function	27926
@NP	lower cavity area	27926
@NP	motor function	27948
@NP	higher open-field BBB score and superior SEP.	27966
@NP	higher open-field BBB score	27966
@NP	superior SEP.	27998
@NP	Inflammation	28012
@NP	a part of the initial response to the injury of CNS	28028
@NP	a part	28028
@NP	the initial response to the injury of CNS	28038
@NP	the initial response	28038
@NP	the injury of CNS	28062
@NP	the injury	28062
@NP	CNS	28076
@NP	the acute phase	28104
@NP	disruption of the blood brain/spinal barrier	28123
@NP	disruption	28123
@NP	the blood brain/spinal barrier	28137
@NP	accumulation of immune cells and proteins	28174
@NP	accumulation	28174
@NP	immune cells and proteins	28190
@NP	the acute phase , which typically lasts for a few hours	28224
@NP	the acute phase	28224
@NP	a few hours	28267
@NP	pro-inflammatory cytokines	28280
@NP	-LSB- 25 , 26 -RSB-	28323
@NP	This phase	28333
@NP	an augmentation in damage	28364
@NP	an augmentation	28364
@NP	damage	28383
@NP	-LSB- 25 , 27 -RSB-	28390
@NP	the sub-acute phase	28403
@NP	between 2 and 7 days after injury	28424
@NP	between 2 and 7 days	28424
@NP	injury	28451
@NP	the levels of some pro-inflammatory cytokines	28459
@NP	the levels	28459
@NP	some pro-inflammatory cytokines	28473
@NP	the number of macrophages and T cells	28535
@NP	the number	28535
@NP	macrophages and T cells	28549
@NP	the levels of anti-inflammatory factors	28590
@NP	the levels	28590
@NP	anti-inflammatory factors	28604
@NP	-LSB- 26 , 28 -RSB-	28641
@NP	It	28651
@NP	inflammation	28678
@NP	regeneration	28703
@NP	the later phase	28719
@NP	-LSB- 28 , 29 -RSB-	28735
@NP	the characteristic of the sub-acute phase	28756
@NP	the characteristic	28756
@NP	the sub-acute phase	28778
@NP	a transformation from aggravation to repair of SCI -LSB- 30 , 31 -RSB-	28801
@NP	a transformation	28801
@NP	aggravation to repair of SCI -LSB- 30 , 31 -RSB-	28823
@NP	aggravation	28823
@NP	repair of SCI -LSB- 30 , 31 -RSB-	28838
@NP	repair	28838
@NP	SCI -LSB- 30 , 31 -RSB-	28848
@NP	co-transplantation ofOECs and SCs	28874
@NP	the inflammation microenvironment	28923
@NP	the sub-acute phase	28972
@NP	SCI	28998
@NP	The chemotactic factor -LRB- CCL2 and CCL3 -RRB-	29003
@NP	The chemotactic factor	29003
@NP	CCL2 and CCL3	29027
@NP	CCL2	29027
@NP	CCL3	29036
@NP	astrocytes and microglias	29054
@NP	an injured region	29113
@NP	Astrocytes and microglias	29132
@NP	major immune mediators	29159
@NP	the CNS	29185
@NP	release amounts of inflammatory factors in an inflammatory cascade	29194
@NP	release amounts	29194
@NP	inflammatory factors in an inflammatory cascade	29213
@NP	inflammatory factors	29213
@NP	an inflammatory cascade	29237
@NP	secondary pathological damage	29277
@NP	Activated astrocytes	29308
@NP	glial scars	29343
@NP	axonal regeneration and repair of nerve cells	29368
@NP	axonal regeneration and repair	29368
@NP	nerve cells	29402
@NP	-LSB- 32 , 33	29414
@NP	microglias	29434
@NP	macrophages , which phagocytize debris and degenerated myelin sheath	29464
@NP	macrophages	29464
@NP	debris	29495
@NP	myelin sheath	29518
@NP	The reduced CCL2 and CCL3 expression	29533
@NP	the restriction of monocyte/macrophage infiltration	29586
@NP	the restriction	29586
@NP	monocyte/macrophage infiltration	29605
@NP	the CNS -LSB- 34 -RSB-	29643
@NP	the CNS	29643
@NP	34 -RSB-	29652
@NP	It	29657
@NP	this study	29676
@NP	co-transplantation of OECs and SCs	29692
@NP	co-transplantation	29692
@NP	OECs and SCs	29714
@NP	the expression of CCL2 and CCL3	29749
@NP	the expression	29749
@NP	CCL2 and CCL3	29767
@NP	the activation of astrocytes , as well as the infiltration of macrophages	29799
@NP	the activation of astrocytes	29799
@NP	the activation	29799
@NP	astrocytes	29817
@NP	the infiltration of macrophages	29840
@NP	the infiltration	29840
@NP	macrophages	29860
@NP	Astrocytes	29873
@NP	a major type of gliocyte	29888
@NP	a major type	29888
@NP	gliocyte	29904
@NP	a key role	29922
@NP	nerve regeneration in the CNS	29936
@NP	nerve regeneration	29936
@NP	the CNS	29958
@NP	it	29979
@NP	astrocytes	30005
@NP	hypertrophy	30024
@NP	contact with SCs	30044
@NP	contact	30044
@NP	SCs	30057
@NP	OECs	30074
@NP	35 -RSB-	30089
@NP	our previous study in vivo	30104
@NP	our previous study	30104
@NP	vivo	30126
@NP	SCs	30146
@NP	more GFAP expression	30157
@NP	OECs	30183
@NP	SCs	30193
@NP	OECs on the reaction of astrocytes -LSB- 17 -RSB-	30209
@NP	OECs	30209
@NP	the reaction of astrocytes -LSB- 17 -RSB-	30217
@NP	the reaction	30217
@NP	astrocytes -LSB- 17 -RSB-	30233
@NP	astrocytes	30233
@NP	17 -RSB-	30245
@NP	the present study	30253
@NP	the expression of GFAP in the co-transplantation group	30272
@NP	the expression	30272
@NP	GFAP in the co-transplantation group	30290
@NP	GFAP	30290
@NP	the co-transplantation group	30298
@NP	that of other groups	30356
@NP	that	30356
@NP	other groups	30364
@NP	the co-transplantation of SCs and OECs	30386
@NP	the co-transplantation	30386
@NP	SCs and OECs	30412
@NP	a synergistic effect rather than a superposition effect	30432
@NP	a synergistic effect	30432
@NP	a superposition effect	30465
@NP	the astrocytes	30491
@NP	the mechanisms for this synergistic effect	30511
@NP	the mechanisms	30511
@NP	this synergistic effect	30530
@NP	further studied	30564
@NP	further	30564
@NP	Macrophages	30581
@NP	a type of highly differentiated	30604
@NP	a type	30604
@NP	mature mononuclear phagocytic cell	30637
@NP	monocytes	30697
@NP	blood	30725
@NP	the tissues and microglias that reside in the CNS	30734
@NP	the tissues and microglias	30734
@NP	the CNS	30776
@NP	Macrophages	30785
@NP	a heterogeneous cell population	30801
@NP	different functions	30844
@NP	the microenvironment	30877
@NP	-LSB- 13 , 36 -RSB-	30898
@NP	The activation of macrophages	30908
@NP	The activation	30908
@NP	macrophages	30926
@NP	the expression of receptors , cytokines , and chemokines	30954
@NP	the expression	30954
@NP	receptors , cytokines , and chemokines	30972
@NP	differences in effector functions	31021
@NP	differences	31021
@NP	effector functions	31036
@NP	IFN-γ-induced macrophages	31056
@NP	oxidative metabolism	31090
@NP	the expression of pro-inflammatory factors	31126
@NP	the expression	31126
@NP	pro-inflammatory factors	31144
@NP	anti-infective effects	31184
@NP	positive immune responses	31215
@NP	the concomitant release of oxidative metabolites and proteolytic enzymes	31251
@NP	the concomitant release	31251
@NP	oxidative metabolites and proteolytic enzymes	31278
@NP	oxidative metabolites	31278
@NP	proteolytic enzymes	31304
@NP	neurons and glial cells	31337
@NP	neurons	31337
@NP	glial cells	31349
@NP	toxic effects	31371
@NP	neurons	31388
@NP	IL-4-induced macrophages	31397
@NP	immune responses	31435
@NP	angiogenesis	31461
@NP	pro-inflammatory responses	31483
@NP	the immune escape of pathogens	31519
@NP	the immune escape	31519
@NP	pathogens	31540
@NP	the regeneration and growth of mature sensory axons -LSB- 37	31563
@NP	the regeneration and growth	31563
@NP	mature sensory axons -LSB- 37	31594
@NP	mature sensory axons	31594
@NP	37	31616
@NP	The r	31625
@NP	s u	31633
@NP	s	31633
@NP	u	31635
@NP	l	31637
@NP	t s of the present s tudy	31639
@NP	t s	31639
@NP	the present s tudy	31646
@NP	co-transplantation of OECs and SCs	31677
@NP	co-transplantation	31677
@NP	OECs and SCs	31699
@NP	the M -LRB- IL-4 -RRB- increase	31726
@NP	IL-4	31733
@NP	the M -LRB- IFN-γ -RRB-	31758
@NP	the M	31758
@NP	IFN-γ	31764
@NP	numbers	31771
@NP	IL-6 and TNF-α , major pro-inflammatory factors ,	31780
@NP	IL-6 and TNF-α	31780
@NP	major pro-inflammatory factors	31796
@NP	immune functions and inflammatory responses	31849
@NP	immune functions	31849
@NP	inflammatory responses	31870
@NP	These factors	31894
@NP	the formation of immune molecules including antibodies and complement	31943
@NP	the formation	31943
@NP	immune molecules including antibodies and complement	31960
@NP	immune molecules	31960
@NP	antibodies and complement	31987
@NP	antibodies	31987
@NP	complement	32002
@NP	extensive inflammatory responses	32028
@NP	the chemotactic effects	32069
@NP	degranulation of neutrophils and monocytes/macrophages	32097
@NP	degranulation	32097
@NP	neutrophils and monocytes/macrophages	32114
@NP	29 -RSB-	32153
@NP	the CNS	32161
@NP	synthesis or secretion of these pro-inflammatory factors	32170
@NP	synthesis or secretion	32170
@NP	these pro-inflammatory factors	32196
@NP	neuronal degeneration	32235
@NP	the progression of repair and regeneration	32274
@NP	the progression	32274
@NP	repair and regeneration	32293
@NP	39 -RSB-	32318
@NP	trace levels of these cytokines	32336
@NP	trace levels	32336
@NP	these cytokines	32352
@NP	cascade effects	32381
@NP	inflammatory responses	32422
@NP	the internal environment of the CNS -LSB- 31 -RSB-	32462
@NP	the internal environment	32462
@NP	the CNS -LSB- 31 -RSB-	32490
@NP	the CNS	32490
@NP	31 -RSB-	32499
@NP	levels of pro-inflammatory factors	32514
@NP	levels	32514
@NP	pro-inflammatory factors	32524
@NP	the damage caused by excessive immune cell activation	32561
@NP	the damage	32561
@NP	excessive immune cell activation	32582
@NP	the subsequent cytotoxic and apoptotic effects	32631
@NP	addition	32682
@NP	the increased expression	32692
@NP	secretion of anti-inflammatory factors -LRB- IL-10 and IL-13 -RRB-	32721
@NP	secretion	32721
@NP	anti-inflammatory factors -LRB- IL-10 and IL-13 -RRB-	32734
@NP	anti-inflammatory factors	32734
@NP	IL-10 and IL-13	32761
@NP	IL-10	32761
@NP	IL-13	32771
@NP	immune-mediated damage caused by excessive inflammation -LSB- 40 , 41 -RSB-	32798
@NP	immune-mediated damage	32798
@NP	excessive inflammation	32831
@NP	-LSB- 40 , 41 -RSB-	32854
@NP	The present results	32864
@NP	co-transplantation of OECs and SCs	32896
@NP	co-transplantation	32896
@NP	OECs and SCs	32918
@NP	the immune microenvironment	32945
@NP	the injured area	32976
@NP	selective anti-inflammatory effects	33000
@NP	the damage caused by harmful immune responses	33047
@NP	the damage	33047
@NP	harmful immune responses	33068
@NP	neuro-protective effects	33116
@NP	summary	33145
@NP	the findings of the present study	33154
@NP	the findings	33154
@NP	the present study	33170
@NP	co-transplantation of OECs and SCs	33198
@NP	co-transplantation	33198
@NP	OECs and SCs	33220
@NP	the activation and infiltration of inflammatory cells	33243
@NP	the activation and infiltration	33243
@NP	inflammatory cells	33278
@NP	macrophage activation	33311
@NP	the M -LRB- IL-4 -RRB- phenotype rather than M	33336
@NP	the M -LRB- IL-4 -RRB- phenotype	33336
@NP	M	33370
@NP	IFN-γ	33373
@NP	This effect	33381
@NP	the changes	33427
@NP	anti- and/or pro-inflammatory factor expression	33442
@NP	anti-	33442
@NP	pro-inflammatory factor expression	33455
@NP	an inflammatory response environment	33505
@NP	repair of the structure and function of the injured spinal cord	33554
@NP	repair	33554
@NP	the structure and function of the injured spinal cord	33564
@NP	the structure and function	33564
@NP	the injured spinal cord	33594
@VP	is important in regulation of the repair process	338
@VP	are important donor cells for repairing SCI in different animal models	447
@VP	repairing SCI in different animal models	477
@VP	have not been extensively investigated	618
@VP	been extensively investigated	627
@VP	extensively investigated	632
@VP	containing OECs and SCs	887
@VP	had a more extensive distribution of the grafted cells	1076
@VP	increased arginase + / CD206 + macrophages -LRB- IL-4 -RRB-	1328
@VP	decreased iNOS +	1378
@VP	was followed by higher IL-10 and IL-13	1431
@VP	followed by higher IL-10 and IL-13	1435
@VP	improved motor functions	1557
@VP	reduce inflammatory cell infiltration in the injured site	1719
@VP	provide a better immune environment for SCI repair	1844
@VP	include	2090
@VP	are activated for expressing inflammatory factors	2260
@VP	activated for expressing inflammatory factors	2264
@VP	expressing inflammatory factors	2278
@VP	can exacerbate tissue damage or promote tissue repair -LSB- 1 , 2	2426
@VP	exacerbate tissue damage or promote tissue repair -LSB- 1 , 2	2430
@VP	exacerbate tissue damage	2430
@VP	promote tissue repair -LSB- 1 , 2	2458
@VP	is one of the most promising methods for the treatment of SCI	2520
@VP	can replace necrotic or apoptotic neural cells	2879
@VP	replace necrotic or apoptotic neural cells	2883
@VP	promote remyelination	2927
@VP	secrete multiple neurotrophins -LSB- 8 , 9 -RSB-	2954
@VP	secrete basement membrane components including type IV collagen and laminin	2997
@VP	promote axonal regeneration -LSB- 10 -RSB-	3077
@VP	acts synergistically in restoring motor function after SCI -LSB- 11 , 12 -RSB-	3183
@VP	restoring motor function after SCI -LSB- 11 , 12 -RSB-	3207
@VP	regulated by a dynamic balance of the macrophage activation -LSB- 13 -RSB-	3489
@VP	activated by IFN-γ , as means of M -LRB- IFN-γ -RRB- ,	3567
@VP	activated by IL-4 , as means of M -LRB- IL-4 -RRB-	3655
@VP	inhibit harmful immune responses	3699
@VP	promote damage repair -LSB- 14 , 15 -RSB-	3743
@VP	instructing phagocytes in SCI -LSB- 16 -RSB-	3863
@VP	to investigate the synergistic effects on the local inflammation environment	4162
@VP	investigate the synergistic effects on the local inflammation environment	4165
@VP	to observe the histological changes in the injured spinal cord	4243
@VP	observe the histological changes in the injured spinal cord	4246
@VP	was followed by increased percentage of Arg	4456
@VP	followed by increased percentage of Arg	4460
@VP	and reduced percentage of iNOS +	4515
@VP	improve the immune microenvironment	4583
@VP	promote the repair of local tissues	4620
@VP	improve motor function of the contused rats	4661
@VP	approved by the TMMU Institutional Animal Care and Use Committee	4927
@VP	using a previously described method -LSB- 17 -RSB-	5156
@VP	dissected free of meninges and white matter	5256
@VP	minced with scalpel blades	5301
@VP	was then gently dissociated mechanically and washed	5424
@VP	dissociated mechanically and washed	5440
@VP	dissociated mechanically	5440
@VP	washed	5469
@VP	incubated for 1 h in Dulbecco 's modified Eagle medium -LRB- DMEM -RRB-	5501
@VP	supplemented with 10 % fetal calf serum -LRB- FCS , Gibco , USA -RRB-	5573
@VP	removing and washing the non-adherent cells	5638
@VP	reached near confluence	5850
@VP	were passaged	5880
@VP	passaged	5885
@VP	were highly pure with > 95 % co-expressing S100 and p75	6019
@VP	co-expressing S100 and p75	6047
@VP	were collected and adjusted to 1.0 × 105 cells/μl for transplantation	6109
@VP	collected and adjusted to 1.0 × 105 cells/μl for transplantation	6114
@VP	collected	6114
@VP	adjusted to 1.0 ×	6128
@VP	described previously -LSB- 18 -RSB-	6287
@VP	cut into approximately 1 mm3	6426
@VP	washed two to three times in DMEM	6632
@VP	containing DMEM/10 % FCS -LRB- 750 μl/dish -RRB-	6710
@VP	reached a near-confluent monolayer -LRB- 7 -- 10 days -RRB-	6789
@VP	were transferred to new dishes containing fresh medium	6850
@VP	transferred to new dishes containing fresh medium	6855
@VP	containing fresh medium	6881
@VP	was continued for 4 -- 5 weeks	6919
@VP	continued for 4 -- 5 weeks	6923
@VP	comprised primarily SCs	6976
@VP	dissociated following enzymatic digestion and plated as described previously	7019
@VP	dissociated following enzymatic digestion	7019
@VP	plated as described previously	7065
@VP	described previously	7075
@VP	reached near confluence	7112
@VP	were passaged	7142
@VP	passaged	7147
@VP	was evaluated by immunostaining of anti-S100 -LRB- Abcam , USA -RRB-	7178
@VP	evaluated by immunostaining of anti-S100 -LRB- Abcam , USA -RRB-	7182
@VP	stained positively with S100	7262
@VP	were collected and adjusted to 1.0 × 105 cells/μl for transplantation	7302
@VP	collected and adjusted to 1.0 × 105 cells/μl for transplantation	7307
@VP	collected	7307
@VP	adjusted to 1.0 ×	7321
@VP	was performed at the vertebral T10 level without disrupting the dura	7564
@VP	performed at the vertebral T10 level without disrupting the dura	7568
@VP	disrupting the dura	7613
@VP	released from 25 mm above the exposed cord	7712
@VP	were closed in layers	7791
@VP	closed in layers	7796
@VP	resulted in hind limb paralysis in all the animals	7828
@VP	to prevent wound and bladder infections	7974
@VP	prevent wound and bladder infections	7977
@VP	performed twice daily	8039
@VP	using a previously described method -LSB- 17 -RSB-	8162
@VP	were anesthetized	8218
@VP	was re-exposed	8261
@VP	re-exposed	8265
@VP	remained in place for 5 min after each injection	8416
@VP	contused cord at a depth of 0.8 mm at the epicenter of the lesion	8511
@VP	was used	8681
@VP	used	8685
@VP	was used -LRB- mixed suspension of 3 μl SCs and 3 μl OECs -RRB-	8751
@VP	used -LRB- mixed suspension of 3 μl SCs and 3 μl OECs -RRB-	8755
@VP	were injected with identical volumes of DMEM at the same sites	8822
@VP	injected with identical volumes of DMEM at the same sites	8827
@VP	were closed with interrupted sutures	8927
@VP	closed with interrupted sutures	8932
@VP	selected from every fifth serial section	9067
@VP	prepared from the five host cords selected at random from each group	9112
@VP	selected at random from each group	9146
@VP	collected at × 20	9206
@VP	montaged with Adobe Photoshop 10.0 to facilitate measurements	9227
@VP	to facilitate measurements	9262
@VP	facilitate measurements	9265
@VP	centered on the impact site	9766
@VP	embedded in optimal cutting temperature compound -LRB- OCT -RRB-	9799
@VP	stored at − 70 °C -LRB- n = 3 rats / group -RRB-	9947
@VP	were air-dried and washed in PBS for 10 min	9991
@VP	washed in PBS for 10 min	10010
@VP	were permeabilized with 0.3 % Triton X-100	10049
@VP	blocked with 10 % normal goat serum in 0.01 M PBS for 2 h.	10096
@VP	were counterstained with hematoxylin	10739
@VP	counterstained with hematoxylin	10744
@VP	selected from every fifth serial section	11148
@VP	prepared from three animals	11193
@VP	were photographed at 20 × and montaged with Adobe Photoshop 10.0	11244
@VP	photographed at 20 × and montaged with Adobe Photoshop 10.0	11249
@VP	photographed at 20 ×	11249
@VP	montaged with Adobe Photoshop 10.0	11273
@VP	were measured by Image Pro Plus 6.0	11344
@VP	measured by Image Pro Plus 6.0	11349
@VP	was calculated and expressed as a percentage of DMEM group	11432
@VP	calculated and expressed as a percentage of DMEM group	11436
@VP	were selected from every fifth serial section -LRB- n = 6/group -RRB-	11886
@VP	selected from every fifth serial section -LRB- n = 6/group -RRB-	11891
@VP	captured at × 20 using an Olympus CCD camera	11969
@VP	using an Olympus CCD camera	11985
@VP	montaged with Adobe Photoshop 10.0	12017
@VP	was measured using Image Pro Plus 6.0	12080
@VP	measured using Image Pro Plus 6.0	12084
@VP	using Image Pro Plus 6.0	12093
@VP	USA	12158
@VP	5 mm long centered on the injury epicenter	12202
@VP	were obtained at 1 week after transplantation	12245
@VP	obtained at 1 week after transplantation	12250
@VP	subjected to SDS PAGE -LRB- 12 % gels ; n = 3/group -RRB-	12456
@VP	using standard techniques	12531
@VP	loaded into each well	12588
@VP	were visualized with a chemiluminescence system -LRB- GE Healthcare , UK -RRB-	13178
@VP	visualized with a chemiluminescence system -LRB- GE Healthcare , UK -RRB-	13183
@VP	were analyzed using Quantity One 4.2.1 software -LRB- Bio-Rad , USA -RRB-	13256
@VP	analyzed using Quantity One 4.2.1 software -LRB- Bio-Rad , USA -RRB-	13261
@VP	using Quantity One 4.2.1 software -LRB- Bio-Rad , USA -RRB-	13270
@VP	was expressed relative to that of β-actin	13347
@VP	expressed relative to that of β-actin	13351
@VP	5 mm long centered on the epicenter	13785
@VP	were obtained at 1 week after transplantation -LRB- n = 3 / group -RRB-	13821
@VP	obtained at 1 week after transplantation -LRB- n = 3 / group -RRB-	13826
@VP	were then centrifuged -LRB- 20,000 × g , 4 °C for 30 min -RRB-	14022
@VP	centrifuged -LRB- 20,000 × g , 4 °C for 30 min -RRB-	14032
@VP	using a microplate reader -LRB- Molecular Devices SpectraMax M5 -RRB- at 450 nm	14228
@VP	tested for locomotor function by two observers blinded to the treatment groups	14419
@VP	blinded to the treatment groups	14466
@VP	fixed stereotaxically	14770
@VP	reducing tracheal secretions	14844
@VP	placed on the surface of the sensorimotor cortex	15165
@VP	was analyzed in terms of latency and amplitude	15288
@VP	analyzed in terms of latency and amplitude	15292
@VP	are expressed as mean ± standard deviation	15368
@VP	expressed as mean ± standard deviation	15372
@VP	were determined using one-way factorial analysis of variance -LRB- ANOVA -RRB-	15436
@VP	determined using one-way factorial analysis of variance -LRB- ANOVA -RRB-	15441
@VP	using one-way factorial analysis of variance -LRB- ANOVA -RRB-	15452
@VP	< 0.05 denoted statistical significance	15581
@VP	using SPSS software version 17.0 -LRB- SPSS Inc. , Chicago , IL , USA -RRB-	15661
@VP	was greater	16028
@VP	was more extensive than that in the other groups at 6 weeks post-transplantation	16061
@VP	bar = 200 μm Fig. 2 SC + OEC cotransplantation	16149
@VP	bar = 50 μm	16536
@VP	= 50 μm	16539
@VP	induced macrophages , at 1 week post-transplantation	17179
@VP	decreased , and the number of arginase-1	17309
@VP	decreased	17309
@VP	the number of arginase-1	17324
@VP	were significantly increased	17804
@VP	significantly increased	17809
@VP	reduced the area of cystic cavities induced by SCI	17921
@VP	induced by SCI	17957
@VP	bar = 1 cm in the photographs of the injured spinal cord	18017
@VP	= 1 cm in the photographs of the injured spinal cord	18020
@VP	bar = 1 mm in the micrographs	18079
@VP	= 1 mm in the micrographs	18082
@VP	be recorded in all experiment groups at the sixth week after transplantation	18719
@VP	recorded in all experiment groups at the sixth week after transplantation	18722
@VP	was increased	18811
@VP	increased	18815
@VP	were measured at 1 week and 6 weeks post-transplantation	19092
@VP	measured at 1 week and 6 weeks post-transplantation	19097
@VP	Transplanted	19150
@VP	formed clusters with only very limited cell migration outward	19183
@VP	was observed at 6 weeks post-transplantation	19478
@VP	observed at 6 weeks post-transplantation	19482
@VP	showed that the grafted cells survived until 6 weeks	19850
@VP	survived until 6 weeks	19880
@VP	Changed the Expression Levels of Chemokines	20983
@VP	Inducing Factor of Macrophages The expression of chemokines	21031
@VP	were detected by Western blotting and ELISA	21339
@VP	detected by Western blotting and ELISA	21344
@VP	synergistically reduced the levels of IFN-γ , CCL2 , and CCL3	21460
@VP	increased the levels of IL-4 -LRB- P < 0.05 , vs.	21524
@VP	were also found by ELISA -LRB- P < 0.05 , Fig. 3c -RRB-	21675
@VP	found by ELISA -LRB- P < 0.05 , Fig. 3c -RRB-	21685
@VP	are the markers of M -LRB- IL-4 -RRB-	22037
@VP	showed that a lower proportion of iNOS	22077
@VP	determined to elucidate the functions and mechanisms of inflammatory cells	22717
@VP	to elucidate the functions and mechanisms of inflammatory cells	22728
@VP	elucidate the functions and mechanisms of inflammatory cells	22731
@VP	were determined by Western blotting	22875
@VP	determined by Western blotting	22880
@VP	synergistically reduced the levels of IL-6 and TNF-α	22971
@VP	increased the levels of IL-10 and IL-13 -LRB- P < 0.05 , vs.	23029
@VP	can reduce expression of pro-inflammatory factors -LRB- TNF-α and IL-6 -RRB-	23166
@VP	reduce expression of pro-inflammatory factors -LRB- TNF-α and IL-6 -RRB-	23170
@VP	Reduced the Area of Cystic Cavities At 6 weeks post-transplantation	23363
@VP	were found -LRB- 6.083 ± 0.566 mm2 -RRB- in the DMEM group	23633
@VP	found -LRB- 6.083 ± 0.566 mm2 -RRB- in the DMEM group	23638
@VP	-LRB- 6.083 ± 0.566 mm2 -RRB- in the DMEM group	23644
@VP	was assessed using the BBB score -LRB- n = 6 / group -RRB-	23978
@VP	assessed using the BBB score -LRB- n = 6 / group -RRB-	23982
@VP	using the BBB score -LRB- n = 6 / group -RRB-	23991
@VP	were paraplegic with no observable hind limb movement -LRB- BBB = 0 -RRB-	24061
@VP	was noted in the hind limbs of the rats at 1 week	24174
@VP	noted in the hind limbs of the rats at 1 week	24178
@VP	reaching a functional plateau -LRB- BBB = 7.00 ± 1.25 -RRB- at 6 weeks	24279
@VP	showed markedly better functional recovery , with a significantly increased BBB	24533
@VP	could be recorded in all the experimental groups -LRB- Fig. 8 -RRB-	24794
@VP	be recorded in all the experimental groups -LRB- Fig. 8 -RRB-	24800
@VP	recorded in all the experimental groups -LRB- Fig. 8 -RRB-	24803
@VP	was increased	24867
@VP	increased	24871
@VP	contused model of SCI	25234
@VP	reduce the activation of astrocytes and infiltration of microglias/macrophages	25706
@VP	were also decreased	25874
@VP	also decreased	25879
@VP	increase the amount of M -LRB- IL-4 -RRB- macrophages	25971
@VP	accompanied with increased expression of IL-4	26061
@VP	decreased expression of IFN-γ	26111
@VP	observed in the contused rats	26547
@VP	have shown that OECs and SCs share several common features -LSB- 20 -- 22 -RSB-	26595
@VP	shown that OECs and SCs share several common features -LSB- 20 -- 22 -RSB-	26600
@VP	share several common features -LSB- 20 -- 22 -RSB-	26624
@VP	favors the repair of damage	27000
@VP	allowing extensive distribution	27084
@VP	have lesser capacity for migration	27189
@VP	have greater remyelination ability -LSB- 17 , 24 -RSB-	27228
@VP	leading to more extensive distribution in the damaged areas	27737
@VP	is a part of the initial response to the injury of CNS	28025
@VP	lasts for a few hours	28257
@VP	are upregulated -LSB- 25 , 26 -RSB-	28307
@VP	upregulated -LSB- 25 , 26 -RSB-	28311
@VP	has been defined by an augmentation in damage -LSB- 25 , 27 -RSB-	28344
@VP	been defined by an augmentation in damage -LSB- 25 , 27 -RSB-	28348
@VP	defined by an augmentation in damage -LSB- 25 , 27 -RSB-	28353
@VP	start to decrease	28505
@VP	to decrease	28511
@VP	decrease	28514
@VP	is increased	28573
@VP	increased	28576
@VP	are higher -LSB- 26 , 28 -RSB-	28630
@VP	may support regeneration in the later phase -LSB- 28 , 29 -RSB-	28691
@VP	support regeneration in the later phase -LSB- 28 , 29 -RSB-	28695
@VP	is a transformation from aggravation to repair of SCI -LSB- 30 , 31 -RSB-	28798
@VP	regulating the inflammation microenvironment	28912
@VP	was focused on the sub-acute phase after SCI	28957
@VP	focused on the sub-acute phase after SCI	28961
@VP	to be active and accumulative in an injured region	29080
@VP	be active and accumulative in an injured region	29083
@VP	exacerbate secondary pathological damage	29266
@VP	block axonal regeneration and repair of nerve cells -LSB- 32 , 33	29362
@VP	Activated	29424
@VP	phagocytize debris and degenerated myelin sheath	29483
@VP	phagocytize debris	29483
@VP	degenerated myelin sheath	29506
@VP	significantly reduced the expression of CCL2 and CCL3	29727
@VP	are a major type of gliocyte	29884
@VP	play a key role in nerve regeneration in the CNS	29917
@VP	undergo hypertrophy when in contact with SCs	30016
@VP	not with OECs in vitro -LSB- 35 -RSB-	30065
@VP	confirmed that SCs induce more GFAP expression than OECs	30131
@VP	induce more GFAP expression than OECs	30150
@VP	differ from OECs on the reaction of astrocytes -LSB- 17 -RSB-	30197
@VP	played a synergistic effect rather than a superposition effect on the astrocytes	30425
@VP	should be further studied	30554
@VP	be further studied	30561
@VP	studied	30572
@VP	are a type of highly differentiated	30600
@VP	highly differentiated	30614
@VP	migrate from blood to the tissues and microglias that reside in the CNS	30712
@VP	reside in the CNS	30766
@VP	exert different functions depending on the microenvironment -LSB- 13 , 36 -RSB-	30838
@VP	promote oxidative metabolism	31082
@VP	upregulate the expression of pro-inflammatory factors	31115
@VP	thus exerting anti-infective effects through positive immune responses	31170
@VP	could damage neurons and glial cells , exerting toxic effects on neurons	31324
@VP	damage neurons and glial cells , exerting toxic effects on neurons	31330
@VP	exerting toxic effects on neurons	31362
@VP	improve angiogenesis	31453
@VP	inhibit pro-inflammatory responses , mediate the immune escape of pathogens	31475
@VP	promote the regeneration and growth of mature sensory axons -LSB- 37	31555
@VP	promote the M -LRB- IL-4 -RRB- increase	31718
@VP	limit the M -LRB- IFN-γ -RRB-	31752
@VP	mediate and regulate immune functions and inflammatory responses	31828
@VP	mediate	31828
@VP	regulate immune functions and inflammatory responses	31840
@VP	influence the formation of immune molecules including antibodies and complement	31933
@VP	preventing the progression of repair and regeneration -LSB- 39 -RSB-	32263
@VP	increase inflammatory responses	32413
@VP	also destroy the internal environment of the CNS -LSB- 31 -RSB-	32449
@VP	Decreased levels of pro-inflammatory factors	32504
@VP	prevent the damage caused by excessive immune cell activation	32553
@VP	caused by excessive immune cell activation	32572
@VP	thus reduce the subsequent cytotoxic and apoptotic effects	32619
@VP	caused by excessive inflammation -LSB- 40 , 41 -RSB-	32821
@VP	could improve the immune microenvironment in the injured area	32931
@VP	improve the immune microenvironment in the injured area	32937
@VP	exert selective anti-inflammatory effects	32994
@VP	alleviate the damage caused by harmful immune responses	33037
@VP	caused by harmful immune responses	33058
@VP	result in neuro-protective effects	33106
@VP	inhibited the activation and infiltration of inflammatory cells	33233
@VP	favors repair of the structure and function of the injured spinal cord	33547
